<SEC-DOCUMENT>0001178913-21-003829.txt : 20211209
<SEC-HEADER>0001178913-21-003829.hdr.sgml : 20211209
<ACCEPTANCE-DATETIME>20211209161017
ACCESSION NUMBER:		0001178913-21-003829
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20211209
FILED AS OF DATE:		20211209
DATE AS OF CHANGE:		20211209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ellomay Capital Ltd.
		CENTRAL INDEX KEY:			0000946394
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRIC SERVICES [4911]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35284
		FILM NUMBER:		211482053

	BUSINESS ADDRESS:	
		STREET 1:		9 ROTHSCHILD BLVD.
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6688112
		BUSINESS PHONE:		011-972-3-797-1111

	MAIL ADDRESS:	
		STREET 1:		9 ROTHSCHILD BLVD.
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6688112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUR MACROPRINTERS LTD
		DATE OF NAME CHANGE:	19980331

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUR ADVANCED TECHNOLOGIES LTD
		DATE OF NAME CHANGE:	19950607
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2126946.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using EDGARfilings PROfile 7.7.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div id="DSPFPageHeader"><br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">UNITED STATES</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Washington, D.C. 20549</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">FORM 6-K</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">PURSUANT TO RULE 13a-16 OR 15d-16</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">UNDER THE SECURITIES EXCHANGE ACT OF 1934</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">For the month of December 2021</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Commission File Number: 001-35284</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;"><u>Ellomay Capital Ltd.</u></div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(Translation of registrant&#8217;s name into English)</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>18 Rothschild Blvd., Tel Aviv 6688121, Israel</u></div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(Address of principal executive office)</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;">Form 20-F &#9746;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Form 40-F &#9744;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the
        information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;">Yes &#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; No &#9746;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">If &#8220;Yes&#8221; is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ________</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; line-height: 1.25;">THE TEXT OF EXHIBIT 99.2 OF THIS FORM 6-K IS HEREBY INCORPORATED BY REFERENCE INTO THE REGISTRANT&#8217;S REGISTRATION STATEMENTS ON FORM
        F-3 (NOS. 333-199696 AND 333-144171) AND FORM S-8 (NOS. 333-187533, 333-102288 AND 333-92491), AND TO BE A PART THEREOF FROM THE DATE ON WHICH THIS REPORT IS SUBMITTED, TO THE EXTENT NOT SUPERSEDED BY DOCUMENTS OR REPORTS SUBSEQUENTLY FILED OR
        FURNISHED.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">This Report on Form 6-K of Ellomay Capital Ltd. consists of the following documents, which are attached hereto and incorporated by
        reference herein:</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z3b2fcaa4d3c640ae9445cb63df75c6b2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;"><a href="exhibit_99-1.htm">Exhibit
                99.1</a></td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><a href="exhibit_99-1.htm">Press Release: &#8220;Ellomay Capital Ltd. Announces
                  2022 Extraordinary General Meeting of Shareholders,&#8221; dated December 9, 2021.</a></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zf26c8e7c79e14c64ae760ccc5bcc0ca8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;"><a href="exhibit_99-2.htm">Exhibit
                99.2</a></td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><a href="exhibit_99-2.htm">Notice of Extraordinary General Meeting of
                  Shareholders and Proxy Statement, dated December 9, 2021.</a></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="438a482436a34ee9adb646d498846c09" class="DSPFListTable">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;"><a href="exhibit_99-3.htm">Exhibit
                99.3</a></td>
            <td style="width: auto; vertical-align: top; text-align: justify;"><a href="exhibit_99-3.htm">Proxy Card for Extraordinary General Meeting of Shareholders.</a></td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Signatures</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report
        to be signed on its behalf by the undersigned, thereunto duly authorized.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="zeecd5cb67eb24542a69d25ceaff967f5">

            <tr>
              <td style="width: 50.00%;">
                <div>&#160;</div>
              </td>
              <td style="width: 50%;">
                <div>
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Ellomay Capital Ltd.</div>
                  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                  </div>
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">By: <font style="font-style: italic;"><u>/s/
                        Ran Fridrich</u></font></div>
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Ran Fridrich</div>
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Chief Executive Officer and Director</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 50.00%;">
                <div>&#160;</div>
              </td>
              <td style="width: 50.00%;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; text-indent: -216pt; margin-left: 216pt; line-height: 1.25;">Dated: December 9, 2021</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
  </div>
  <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using EDGARfilings PROfile 7.7.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 99.1</font></u></div>
  </div>
  <div>
    <div id="DSPFPageHeader">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25;"><img width="174" height="67" src="image0.jpg"></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">Ellomay Capital Ltd. Announces 2022 Extraordinary General Meeting of Shareholders</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-right: 0.75pt; line-height: 1.25;">Tel-Aviv, Israel, December 9, 2021 &#8211; <font style="font-weight: bold;">Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (&#8220;Ellomay&#8221; or the &#8220;Company&#8221;)</font>,<font style="font-weight: bold;">&#160;</font>a renewable energy and power generator
      and developer of renewable energy and power projects in Europe and Israel,<font style="font-weight: bold;">&#160;</font>today announced that it will hold an extraordinary general meeting of
      shareholders (the &#8220;<font style="font-weight: bold;">Meeting</font>&#8221;) at the Company&#8217;s offices at 18 Rothschild Boulevard, 1<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> Floor, Tel Aviv 6688121, Israel, on Thursday,
      January 20, 2022, at 3:00 p.m., Israel time, and thereafter as it may be adjourned or postponed from time to time.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-right: 0.75pt; line-height: 1.25;">The agenda of the Meeting will be as follows:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z358e6e651de7490f9a8a5b41542fd1f2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Reelection of Dr. Michael J. Anghel an external director for a second three-year term;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z249b1672751243d6927a82587ba4fc62" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Approval of the terms of service of Dr. Anghel as an external director; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z03c9ae4bb8ad4ad9a177dcec09178784" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Approval of grant of options to Dr. Anghel as an external director.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-right: 0.75pt; line-height: 1.25;">Shareholders of record as of the close of business on December 14, 2021 will be entitled to vote at the Meeting or
      any adjournments or postponements thereof. The Company plans to mail a proxy statement that describes the proposals to be considered at the Meeting and a proxy card on or about December 16, 2021. A proxy statement and proxy card will also be
      furnished to the Securities and Exchange Commission on Form 6-K on or about December 9, 2021.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-right: 0.75pt; line-height: 1.25;">Each of the resolutions to be presented at the Meeting requires the affirmative vote of holders of at least a
      majority of the ordinary shares voted, in person or by proxy or via the electronic system of the Israel Securities Authority, at the Meeting on the matter presented for passage. In addition, the approval of the proposals under Items 1 and 3 is also
      required to comply with additional special &#8220;disinterested&#8221; voting requirements as set forth in the proxy statement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-right: 0.75pt; line-height: 1.25;">Shareholders wishing to express their position on an agenda item for the Meeting may do so by submitting a written
      statement to the Company&#8217;s offices at the above address by January 10, 2022. Any position statement received will be furnished to the SEC on Form 6-K, which will be available to the public on the SEC&#8217;s website at http://www.sec.gov and on the
      websites of the Israel Securities Authority and Tel Aviv Stock Exchange at http://www.magna.isa.gov.il or http://maya.tase.co.il/, respectively. Eligible shareholders may present proper proposals for inclusion in the Meeting by submitting their
      proposals to the Company no later than December 16, 2021.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-right: 0.75pt; line-height: 1.25;">Shareholders may vote their ordinary shares by means of a deed of vote or proxy card, which are required to be
      received by the Company, along with the documentation set forth in the proxy statement, by 11:00 a.m., Israel time, on January 20, 2022 (four hours prior to the Meeting), to be counted for the Meeting, or through the electronic system of the Israel
      Securities Authority until six hours prior to the Meeting.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">About Ellomay Capital Ltd.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the
      trading symbol &#8220;ELLO&#8221;. Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe and Israel.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural
      resources industries in Israel, Italy and Spain, including:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z12d515d65d3445dabbf38c56b6dc137a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Approximately&#160;7.9MW of photovoltaic power plants in Spain and a photovoltaic power plant of approximately 9 MW in Israel;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zf9032d6f50b54124abee8830d9acf6ae" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>9.375% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel&#8217;s largest private power plants with production capacity of approximately 860MW,
              representing about 6%-8% of Israel&#8217;s total current electricity consumption;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z71e5be8f965e4cf58feb598c86913c85" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>51% of Talasol, which owns a photovoltaic plant with a peak capacity of 300MW in the municipality of Talav&#225;n, C&#225;ceres, Spain;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z395618be0807451480746e8fadaaca25" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in&#160;the Netherlands, with a green
              gas production capacity of approximately 3 million, 3.8 million and 9.5 million (with a license to produce 7.5 million) Nm3 per year, respectively;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z665f62ae9a4a494da37f1777d5bfe27e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">For more information about Ellomay, visit <u>http://www.ellomay.com</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Information Relating to Forward-Looking Statements</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are
      based on the current expectations and assumptions of the Company&#8217;s management. All statements, other than statements of historical facts, included in this press release regarding the Company&#8217;s plans and objectives, expectations and assumptions of
      management are forward-looking statements.&#160; The use of certain words, including the words &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;believe&#8221; and similar expressions are intended to identify forward-looking statements within the meaning of the
      Private Securities Litigation Reform Act of 1995.&#160; The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company&#8217;s forward-looking
      statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company&#8217;s forward-looking statements in addition to other risks and uncertainties associated with the
      Company&#8217;s business that are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and
      the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><u>Contact:</u></div>
    <div style="line-height: 1.25;">Kalia Rubenbach (Weintraub)</div>
    <div style="line-height: 1.25;">CFO</div>
    <div style="line-height: 1.25;">Tel: +972 (3) 797-1111</div>
    <div style="line-height: 1.25;">Email: <u>hilai@ellomay.com</u></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit_99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using EDGARfilings PROfile 7.7.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 99.2</font></u><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: center; line-height: 1.25;"><img width="177" height="69" src="image0.jpg"></div>
      <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;"> <br>
        </font></div>
      <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">ELLOMAY CAPITAL LTD.</font></div>
      <div style="text-align: center; line-height: 1.25;">18 Rothschild Boulevard, 1<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> Floor</div>
      <div style="line-height: 1.25;">
        <div style="text-align: center; line-height: 1.25;">Tel Aviv 6688121<br>
        </div>
        <div style="text-align: center; line-height: 1.25;">Israel</div>
        <div style="text-align: center; line-height: 1.25;">________________________________</div>
        <div style="text-align: center; line-height: 1.25;"> <br>
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS</font><br>
        <font style="font-weight: bold;">To be held on January 20, 2022</font></div>
      <div style="text-align: center; line-height: 1.25;">3:00 p.m. Israel time</div>
      <div style="text-align: center; line-height: 1.25;">____________________________________</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25;">To Our Shareholders:</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Notice is hereby given that an extraordinary general meeting of shareholders, or the Meeting, of Ellomay Capital Ltd. (also referred to hereinafter as &#8220;Ellomay&#8221; or the &#8220;Company&#8221;)
        will be held at the Company&#8217;s offices at 18 Rothschild Boulevard, 1<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> Floor, Tel Aviv 6688121, Israel on Thursday, January 20, 2022, at 3:00 p.m., Israel time, and thereafter as it may be adjourned or postponed from time to time.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The agenda of the Meeting will be as follows:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z0b8a953f44564d3497b63b773720616d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Reelection of Dr. Michael J. Anghel an external director for a second three-year term;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z2549a23ea093449da146dcdf3c678754" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Approval of the terms of service of Dr. Anghel as an external director; and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z44cd7701ef934a97ad2bdcd41244ab47" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Approval of grant of options to Dr. Anghel as an external director.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold;">
        <div style="text-indent: 36pt; line-height: 1.25; font-weight: bold;">The Company&#8217;s Board of Directors recommends that you vote FOR each of the foregoing proposals, all of which are more fully described in the accompanying proxy statement, or the
          Proxy Statement.</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Only shareholders of record at the close of business on December 14, 2021, or the Record Date, are entitled to notice of, and to vote at, the Meeting or any adjournment(s) or
        postponement(s) thereof.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Company expects that the Proxy Statement and the accompanying proxy card will be mailed to shareholders of record (as set forth above) on or about December 16, 2021.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Each of the resolutions to be presented at the Meeting requires the affirmative vote of holders of at least a majority of the ordinary shares voted in person or by proxy at the
        Meeting on the matter presented for passage. In addition, the approval of the proposals under 1 and 3 is required to comply with additional special &#8220;disinterested&#8221; voting requirements as set forth in the Proxy Statement.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Joint holders of ordinary shares should note that, pursuant to Article 27.6 of the Company&#8217;s Second Amended and Restated Articles of Association, the right to vote at the Meeting
        will be conferred exclusively upon the senior owner among the joint owners attending the Meeting, in person or by proxy, and for this purpose, seniority will be determined by the order in which the names appear in our register of shareholders.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Company knows of no other matters to be submitted at the Meeting other than as specified in this Notice of Extraordinary General Meeting of Shareholders. If any other
        business is properly brought before the Meeting, it is the intention of the persons named as proxies to vote in respect thereof in accordance with the recommendation of the Company&#8217;s Board of Directors.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Shareholders wishing to express their position on an agenda item for the Meeting may do so by submitting a written statement to the Company&#8217;s offices at the above address by
        January 10, 2022. Any position statement received will be furnished to the SEC on Form 6-K, which will be available to the public on the SEC&#8217;s website at http://www.sec.gov and on the websites of the Israel Securities Authority and Tel Aviv Stock
        Exchange at http://www.magna.isa.gov.il or http://maya.tase.co.il/, respectively.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%LCR%2%- % -%-->
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Eligible shareholders may present proper proposals for inclusion in the Meeting by submitting their proposals to the Company no later than December 16, 2021. Should changes be
        made to any proposal or to the agenda of the Meeting after the mailing of this Proxy Statement, the Company will communicate the changes to its shareholders through the publication of a press release, a copy of which will be furnished to the SEC on
        Form 6-K and available to the public at the abovementioned websites.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If your ordinary shares are held through a member of the Tel Aviv Stock Exchange Clearing house, and you intend to vote your shares at the Meeting in person or by proxy you must
        deliver to us, via messenger, registered mail, the electronic voting system of the Israel Securities Authority or email (<u>hilai@ellomay.com</u>), a confirmation of ownership (<font style="font-style: italic;">ishur baalut</font>) issued by the
        applicable bank or broker, confirming your ownership of our ordinary shares as of the Record Date, as required by the Israeli Companies Regulations (Proof of Ownership of Shares for Voting at General Meeting), 5760-2000. You are entitled to receive
        confirmation of ownership in the branch of the exchange member or by mail to your address (in consideration of mailing fees only), if you so requested in advance for a particular securities account. In the event you wish to vote your ordinary
        shares by means of a deed of vote, please deliver by any of the aforementioned means, along with the confirmation of ownership, the completed and executed second part of the Hebrew form of the deed of vote, filed with the Israel Securities
        Authority and Tel Aviv Stock Exchange and available at the websites noted above, <font style="font-weight: bold;">which must be received by the Company by 11:00 a.m., Israel time, on January 20, 2022 (four hours prior to the Meeting), to be
          counted for the Meeting</font>. You will receive from the exchange member who holds the shares on your behalf, by e-mail, for no charge, a link to the text of the deed of vote and to the position notices, if any, unless you notified that you are
        not interested in receiving such links (provided that such notice was provided with respect to a particular securities account and prior to the Record Date). A shareholder is entitled to contact the Company directly and receive the text of the
        Hebrew deed of vote and position notices, if any. Alternatively, shareholders who hold shares through members of TASE may vote electronically via the electronic voting system of the Israel Securities Authority, up to six hours before the time fixed
        for the Meeting (i.e., 9:00 a.m. (Israel time) on January 20, 2022). You should receive instructions about electronic voting from the TASE member through which you hold your shares.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You are cordially invited to attend the Meeting. <font style="font-weight: bold;">Whether or not you plan to be present at the Meeting and regardless of the number of ordinary
          shares you own, you are requested to complete and return the enclosed proxy, which is solicited by the Company&#8217;s Board of Directors, so that your vote may be recorded. The proxy must be received by the Company&#8217;s transfer agent at least 48 hours
          prior to the appointed time of the Meeting or at the Company&#8217;s registered office in Israel at least four (4) hours prior to the appointed time of the Meeting to be counted for the Meeting. </font>You may revoke your appointment of proxy up to
        one hour prior to the Meeting so that you may vote your shares personally.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z768ed80f6e7541d882ac4c671698ac62">

            <tr>
              <td style="width: 50.00%;">
                <div>&#160;</div>
              </td>
              <td style="width: 50%;">
                <div>
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">By Order of the Board of Directors,</div>
                  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                  </div>
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;"><u>/s/ Shlomo Nehama</u></div>
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Shlomo Nehama</div>
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Chairman of the Board of Directors</div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25;"> <br>
        </div>
        <div style="line-height: 1.25;">December 9, 2021</div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">- ii -</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">ELLOMAY CAPITAL LTD.</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">18 Rothschild Boulevard, 1<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> Floor</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;">Tel Aviv 6688121</font><br>
        <font style="font-weight: bold;">Israel</font></div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">____________________________________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">PROXY STATEMENT FOR AN EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS<br>
        To be held on January 20, 2022</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">3:00 p.m. Israel time</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">____________________________________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The extraordinary general meeting of shareholders, or the Meeting, of Ellomay Capital Ltd. (also referred to hereinafter as &#8220;Ellomay<font style="font-weight: bold;">,</font>&#8221; the
        &#8220;Company<font style="font-weight: bold;">,</font>&#8221; &#8220;us,&#8221; &#8220;we&#8221; or &#8220;our&#8221;) will be held at our offices at 18 Rothschild Boulevard, 1<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> Floor, Tel Aviv 6688121, Israel on Thursday, January 20, 2022, at 3:00 p.m., Israel time, and thereafter
        as it may be adjourned or postponed from time to time.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">SOLICITATION OF PROXIES</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">It is proposed that at the Meeting, resolutions be adopted as follows:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="za708380b6e6d480c96ffed371044634e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Reelection of Dr. Michael J. Anghel as an external director for a second three-year term;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z7a843eecc42d462fa2d68e3046bed175" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Approval of terms of service of Dr. Anghel as an external director; and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z50fd6461b74f49feae29f30d2a1b87b9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Approval of grant of options to Dr. Anghel as an external director.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold;">Our Board of Directors recommends that you vote FOR each of the foregoing proposals, all of which are more fully described in this proxy statement, or the
          Proxy Statement.</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The proxy materials are being mailed to our shareholders as of December 14, 2021, or the Record Date, on or about December 16, 2021.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">A form of proxy for use at the Meeting and a return envelope for the proxy are enclosed.&#160; Upon the receipt of a properly signed and dated proxy in the form enclosed, which is
        received in time and not revoked prior to the Meeting, either of the proxies, with full power of substitution, will vote, as proxy, the ordinary shares represented thereby at the Meeting in accordance with the instructions indicated on the proxy,
        or, if no direction is indicated, in accordance with the recommendation of our Board of Directors as set forth below.<font style="font-weight: bold;"> In order to be counted at the Meeting, your proxy must be received either by our transfer agent
          by 3:00 p.m. (Israel time) on January 18, 2022 (forty-eight hours prior to the Meeting), or at our registered office in Israel by 11:00 a.m. (Israel time) on January 20, 2022 (four hours prior to the Meeting).</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The enclosed form of proxy is solicited by our Board of Directors for use at the Meeting and at any adjournments or postponements of the Meeting. All expenses of this
        solicitation will be borne by the Company. In addition to the solicitation of proxies by mail, directors, officers, and employees of the Company, without receiving additional compensation, may solicit proxies by telephone, in person, or by other
        means.&#160; Brokerage firms, nominees, fiduciaries, and other custodians have been requested to forward proxy solicitation materials to the beneficial owners of ordinary shares of the Company held of record by such persons, and the Company will
        reimburse such brokerage, nominees, fiduciaries, and other custodians for reasonable out-of-pocket expenses incurred by them in connection therewith.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The proxy may be revoked at any time prior to its exercise by notice in writing of the shareholder to us, delivered at our address above up to one hour prior to the Meeting and
        indicating that its/his/her proxy is revoked, or by timely submitting another proxy with a later date. If you hold your ordinary shares in &#8220;street name,&#8221; meaning in the name of a bank, broker or other record holder, you must either direct the
        record holder of your ordinary shares on how to vote your ordinary shares or obtain a legal proxy from the record holder to vote such ordinary shares at the Meeting on behalf of the record holder as well as a statement from such record holder that
        it did not vote such ordinary shares.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If your ordinary shares are held through a member of the Tel Aviv Stock Exchange Clearinghouse, and you intend to vote your shares at the Meeting in person or by proxy you must
        deliver to us, via messenger, registered mail, the electronic voting system of the Israel Securities Authority or email (<u>hilai@ellomay.com</u>), a confirmation of ownership (<font style="font-style: italic;">ishur baalut</font>) issued by the
        applicable bank or broker, confirming your ownership of our ordinary shares as of the Record Date, as required by the Israeli Companies Regulations (Proof of Ownership of Shares for Voting at General Meeting), 5760-2000. You are entitled to receive
        confirmation of ownership in the branch of the exchange member or by mail to your address (in consideration of mailing fees only), if you so requested in advance for a particular securities account. In the event you wish to vote your ordinary
        shares by means of a deed of vote, please deliver by any of the aforementioned means, along with the confirmation of ownership, the completed and executed second part of the Hebrew form of the deed of vote, filed with the Israel Securities
        Authority and the Tel Aviv Stock Exchange and available at the websites noted in the notice of the Meeting, <font style="font-weight: bold;">which must be received by us by 11:00 a.m., Israel time, on January 20, 2022 (four hours prior to the
          Meeting), to be counted for the Meeting</font>. You will receive from the exchange member who holds the shares on your behalf, by e-mail, for no charge, a link to the text of the deed of vote and to the position notices, if any, unless you
        notified that you are not interested in receiving such links (provided that such notice was provided with respect to a particular securities account and prior to the Record Date). Alternatively, shareholders who hold shares through members of TASE
        may vote electronically via the electronic voting system of the Israel Securities Authority, or the ISA, up to six hours before the time fixed for the Meeting (i.e., 9:00 a.m. (Israel time) on January 20, 2022). You should receive instructions
        about electronic voting from the TASE member through which you hold your shares.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%- % -%-->
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">RECORD DATE; QUORUM</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Only shareholders of record at the close of business on December 14, 2021 are entitled to notice of, and to vote at, the Meeting or any adjournment(s) or postponement(s) thereof. As of December 8,
          2021, we had 12,849,295 issued and outstanding ordinary shares (this number does not include 258,046 ordinary shares all of which were repurchased by us, that were held by us at that date by us as treasury shares under Israeli law).&#160; Each
          ordinary share, other than ordinary shares held by us as treasury shares, is entitled to be counted for purposes of a quorum and to one vote on each matter to be voted on at the Meeting. Our Second Amended and Restated Articles of Association, or
          the Articles, do not provide for cumulative voting for the election of directors or for any other purpose.</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The presence at the Meeting, in person or by proxy, of two or more shareholders holding more than 25% of the voting rights of the Company, will constitute a quorum. All ordinary
        shares represented in person or by proxy (including broker non-votes and shares that abstain or do not vote with respect to one or more of the matters to be voted upon) will be counted for purposes of determining whether a quorum exists. If within
        half an hour from the time appointed for the Meeting a quorum is not present, the meeting shall stand adjourned on the same day, in the next week, at the same time and place and means of communications. The requisite quorum at an adjourned meeting
        shall be any two or more members, present in person or by proxy at the meeting.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">VOTING RIGHTS; REQUIRED VOTES</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The votes of all shareholders voting on a proposal are counted. Abstentions and broker non-votes will not be treated as either a vote &#8220;for&#8221; or &#8220;against&#8221; a proposal. &#8220;Broker
        non-votes&#8221; are shares held by brokers or other nominees which are present in person or represented by proxy, but which are not voted on a particular matter because instructions have not been received from the beneficial owner of the shares. Brokers
        and other nominees have discretionary voting authority under the applicable rules of the New York Stock Exchange to vote on &#8220;routine&#8221; matters. Please note that the uncontested election of directors is not considered a &#8220;routine&#8221; matter under such
        rules. This means that if a brokerage firm holds your shares on your behalf, those shares will not be voted in the election of directors, or with respect to the other non-routine matters on the agenda of the Meeting, unless you provide voting
        instructions to your brokerage firm or obtain a proxy from your brokerage firm and vote the shares yourself, in person or by proxy.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Each of the resolutions to be presented at the Meeting requires the affirmative vote of holders of at least a majority of the ordinary shares voted in person or by proxy at the
        Meeting on the matter presented for passage. In addition, the approval of the proposals under Items 1 and 3 is required to comply with additional special &#8220;disinterested&#8221; voting requirements as set forth in the Proxy Statement.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">PRINCIPAL SHAREHOLDERS</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">The following table sets forth information regarding the beneficial ownership of our ordinary shares as of December 8, 2021 by each person known by us to be the beneficial owner of 5.0% or more of
          our ordinary shares. Each of our shareholders has identical voting rights with respect to its shares. All of the information with respect to beneficial ownership of the ordinary shares is given to the best of our knowledge based on public filings
          by the shareholders and on information known to us in connection with private placements of our ordinary shares conducted in the recent year.</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">To our knowledge, except as otherwise indicated in the footnotes to this table, each shareholder in the table has sole voting and investment power for the ordinary shares shown
        as beneficially owned by them.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 2 -</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z3ee606e9ec6441c69590c86f82c94c72">

          <tr>
            <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;" colspan="2">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Ordinary Shares<br>
                  Beneficially Owned<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;" colspan="2">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Percentage of Ordinary Shares Beneficially Owned</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25;">Shlomo Nehama <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)(4)(5)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="line-height: 1.25;">3,588,577</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="line-height: 1.25;">27.9</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="line-height: 1.25;">%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="text-align: justify; line-height: 1.25;">Kanir Joint Investments (2005) Limited Partnership <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)(4)(5)</sup></div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="line-height: 1.25;">2,605,845</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="line-height: 1.25;">20.3</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">
              <div style="line-height: 1.25;">%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25;">Yelin Lapidot Holdings Management Ltd.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup></div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="line-height: 1.25;">1,456,332</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="line-height: 1.25;">11.3</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="line-height: 1.25;">%</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="text-align: justify; line-height: 1.25;">Clal Insurance Enterprises Holdings Ltd.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup></div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="line-height: 1.25;">1,137,678</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="line-height: 1.25;">8.9</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1">
              <div style="line-height: 1.25;">%</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: -8.5pt; margin-right: 8.5pt; margin-left: 8.5pt; line-height: 1.25;">___________________________</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zfefa009fb0404373934bacbeb9023299" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.45pt; vertical-align: top; align: right;">&#160;(1)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>As used in this table, &#8220;beneficial ownership&#8221; means the sole or shared power to vote or direct the voting or to dispose or direct the disposition of any security as determined pursuant to Rule 13d-3 promulgated under the U.S. Securities
                Exchange Act of 1934, as amended. For purposes of this table, a person is deemed to be the beneficial owner of securities that can be acquired within 60 days from December 8, 2021 through the exercise of any option or warrant. Ordinary
                shares subject to options or warrants that are currently exercisable or exercisable within 60 days are deemed outstanding for computing the ownership percentage of the person holding such options or warrants, but are not deemed outstanding
                for computing the ownership percentage of any other person. The amounts and percentages are based on a total of 12,849,295 ordinary shares outstanding as of December 8, 2021. This number of outstanding ordinary shares does not include a
                total of 258,046 ordinary shares held at that date as treasury shares under Israeli law, all of which were repurchased by us. For so long as such treasury shares are owned by us they have no rights and, accordingly, are neither eligible to
                participate in or receive any future dividends which may be paid to our shareholders nor are they entitled to participate in, be voted at or be counted as part of the quorum for, any meetings of our shareholders.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z9c9b033888a04d808f5e44b5482e202b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.45pt; vertical-align: top; align: right;">(2)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The 3,588,577 ordinary shares beneficially owned by Mr. Nehama consist of: (i) 3,123,604 ordinary shares held by S. Nechama Investments (2008) Ltd., or Nechama Investments, which constitute approximately 24.3% of our outstanding ordinary
                shares and (ii) 464,973 ordinary shares and held directly by Mr. Nehama, which constitute approximately 3.6% of our outstanding ordinary shares. Mr. Nehama, as the sole officer, director and shareholder of Nechama Investments, may be deemed
                to indirectly beneficially own any ordinary shares owned by Nechama Investments, which constitute (together with his shares) approximately 27.9% of our outstanding ordinary shares.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3f2c48c4847647da9de99f127873f629" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.45pt; vertical-align: top; align: right;">(3)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Kanir Joint Investments (2005) LP, or Kanir, is an Israeli limited partnership. Kanir Investments Ltd., or Kanir Ltd., in its capacity as the general partner of Kanir, has the voting and dispositive power over the ordinary shares
                directly beneficially owned by Kanir. As a result, Kanir Ltd. may be deemed to indirectly beneficially own the ordinary shares beneficially owned by Kanir. Mr. Ran Fridrich, who is a member of our Board of Directors and our Chief Executive
                Officer, and Ms. Anat Raphael, the sister of Mr. Ehud Gil who is a member of our Board of Directors, are the sole directors of Kanir Ltd. As a result, Mr. Fridrich and Ms. Raphael may be deemed to indirectly beneficially own the ordinary
                shares beneficially owned by Kanir. In addition, the estate of Mr. Raphael, who passed away in December 2020, is the majority shareholder of Kanir Ltd. and beneficially owns 254,524 ordinary shares, which constitute approximately 2% of our
                outstanding shares and which constitute, together with Kanir&#8217;s holdings, 22.3% of our outstanding ordinary shares. Each of Kanir Ltd., Mr. Fridrich and Ms. Raphael disclaims beneficial ownership of such ordinary shares except to the extent
                of their respective pecuniary interest therein, if any.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zbe7e70cf5c9a4701a53023729d776e93" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.45pt; vertical-align: top; align: right;">(4)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>By virtue of the 2008 Shareholders Agreement, Mr. Nehama, Nechama Investments, Kanir, Kanir Ltd., Mr. Fridrich and Ms. Raphael may be deemed to be members of a group that holds shared voting power with respect to 5,729,449 ordinary
                shares, which constitute approximately 44.6% of our outstanding ordinary shares, and holds shared dispositive power with respect to 5,232,201 ordinary shares, which constitute 40.8% of our outstanding ordinary shares. Accordingly, taking
                into account the shares directly held by Mr. Nehama, he may be deemed to beneficially own approximately 48.2% of our outstanding ordinary shares and, taking into account the shares directly held by the estate of Mr. Raphael, Ms. Raphael may
                be deemed to beneficially own approximately 46.6% of our outstanding ordinary shares. Each of Mr. Nehama and Nechama Investments disclaims beneficial ownership of the ordinary shares beneficially owned by Kanir. Each of Kanir, Kanir Ltd.,
                Mr. Fridrich and Ms. Raphael disclaims beneficial ownership of the ordinary shares beneficially owned by Nechama Investments. A copy of the 2008 Shareholders Agreement was filed with the Securities and Exchange Commission, or the SEC, on
                March 31, 2008 as Exhibit 14 to an amendment to a Schedule 13D and is not incorporated by reference herein.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zcd9d450441fe4b2d84119dfb368e31d9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.45pt; vertical-align: top; align: right;">(5)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The information included in this table concerning the beneficial ownership of Nechama Investments, Kanir, Kanir Ltd., Messrs. Nehama and Fridrich and Ms. Raphael is based on a Schedule 13D/A submitted on October 13, 2020 and on
                information provided by the shareholders.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z02e93eeb67144a018c84e4303c7c1a41" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.45pt; vertical-align: top; align: right;">(6)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Based on a Schedule 13G/A submitted on February 2, 2021 by Mr. Dov Yelin, Mr. Yair Lapidot, Yelin Lapidot Holdings Management Ltd., or Yelin Lapidot, and Yelin Lapidot Mutual Funds Management Ltd., or Yelin Lapidot Mutual. According to
                the Schedule 13G/A: (i) the securities reported therein are beneficially owned as follows: (a) 971,883 ordinary shares, which constitute approximately 7.6% of our outstanding ordinary shares, by mutual funds managed by Yelin Lapidot Mutual
                and (b) 484,449 ordinary shares, which constitute approximately 3.8% of our outstanding ordinary shares, by provident funds managed by Yelin Lapidot Provident Fund Management Ltd., or Yelin Lapidot Provident, (ii) both Yelin Lapidot Mutual
                and Yelin Lapidot Provident are wholly-owned subsidiaries of Yelin Lapidot and operate under independent management and make their own independent voting and investment decisions, and (iii) Messrs. Yelin and Lapidot each own 24.38% of the
                share capital and 25.004% of the voting rights of Yelin Lapidot, and are responsible for the day-to-day management of Yelin Lapidot. Pursuant to the Schedule 13G/A, any economic interest or beneficial ownership in any of the securities
                covered by the Schedule 13G/A is held for the benefit of the members of the provident funds or mutual funds, as the case may be, and each of Messrs. Yelin and Lapidot, Yelin Lapidot and wholly-owned subsidiaries of Yelin Lapidot, disclaims
                beneficial ownership of any such securities.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z7c050fb55d9a4322b6db9b4a5f51bf5c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.45pt; vertical-align: top; align: right;">(7)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Based on a Schedule 13G/A submitted on February 16, 2021 by Clal Insurance Enterprises Holdings Ltd., or Clal. Based on the Schedule 13G/A, of the 1,137,678 ordinary shares reported as beneficially owned by Clal: (i) 159,678 ordinary
                shares are beneficially held for Clal&#8217;s own account and (ii) 978,000 ordinary shares are held for members of the public through, among others, provident funds and/or pension funds and/or insurance policies, which are managed by subsidiaries
                of Clal, which subsidiaries operate under independent management and make independent voting and investment decisions. Consequently, Clal notes in the Schedule 13G/A that the Schedule 13G/A will not constitute an admission that it is the
                beneficial owner of more than 159,678 ordinary shares.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 3 -</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;MATTERS SUBMITTED TO SHAREHOLDERS</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>ITEM 1</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">REELECTION OF EXTERNAL DIRECTOR</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Background</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Companies incorporated under the laws of Israel whose shares have been offered to the public, such as our company, are required by the Companies Law to have at least two external directors. Each
          external director may serve for up to three terms of three years. However, pursuant to the Israeli Companies Regulations (Relief for Public Companies with Shares Listed for Trading on a Stock Market Outside of Israel), 5760-2000, Israeli
          companies listed on certain stock exchanges outside Israel, including the NYSE American (such as our company), may appoint an external director for additional terms of not more than three years each, subject to certain conditions. Our other
          directors are elected annually.</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Our currently serving external directors are Dr. Michael J. Anghel, whose first service term is due to end on January 23, 2022 and Daniel Vaknin, whose first service term is due to end on December
          19, 2023. Dr. Anghel was elected for his first three-year service term in the general meeting of our shareholders held on January 24, 2019 and is standing for reelection for an additional three-year term, commencing January 24, 2022.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Companies Law prescribes the requirements and qualifications of an external director. Among other requirements and limitations, in order to qualify as an external director an
        individual may not be a relative of a controlling shareholder and she or he, or her or his relative, partner, employer, direct or indirect supervisor or an entity she or he controls, may not have, and may not have had at any time during the
        previous two years, any affiliation to the company, the controlling shareholder of the company or a relative of the controlling shareholder of the company or to an entity that, on the date of appointment of during the preceding two years, is or was
        controlled by the company or by the company&#8217;s controlling shareholder. The term affiliation includes: an employment relationship, a business or professional relationship maintained on a regular basis, control, and service as an office holder. In
        addition, no individual may serve as an external director if the individual&#8217;s position or other activities create or may create a conflict of interest with his or her role as an external director or if she or he, or her or his relative, partner,
        employer, direct or indirect supervisor, or an entity she or he controls, has other than negligible business or professional relations with any of the persons with which the external director himself may not be affiliated, even if such relations
        are not routine. In addition, at least one of the external directors must have &#8220;accounting and financial expertise&#8221; and any other external director must have &#8220;accounting and financial expertise&#8221; or &#8220;professional qualification,&#8221; as such terms are
        defined by regulations promulgated under the Companies Law.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">For a period of two years following the termination of services as an external director, the company, its controlling shareholder and any entity the controlling shareholder
        controls may not provide any benefit to such former external director, directly or indirectly. The prohibited benefits include the appointment as an office holder in the company or the controlled entity, employment of, or receipt of professional
        services from, the former external director for compensation, including through an entity such former external director controls. The same prohibition applies to the former external director&#8217;s spouse and child for the same two-year period and to
        other relatives of the external director for a period of one year following the termination of services as an external director.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">All of the external directors of a company must be members of its audit committee and compensation committee and at least one external director is required to serve on every
        committee authorized to exercise any of the powers of the board of directors. Dr. Anghel serves as the Chairman of our Audit Committee and Compensation Committee.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">At the Meeting, shareholders will be asked to reelect Dr. Anghel as an external director for a second three-year term, commencing January 24, 2022.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are unaware of any reason why Dr. Anghel, if elected, should be unable to serve as a member of our Board of Directors, Audit Committee and Compensation Committee. Dr. Anghel
        advised the Board of Directors that he intends to serve as a member of the Board of Directors, Audit Committee and Compensation Committee if elected.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the requirements of Section 241 of the Companies Law, Dr. Anghel provided us with a &#8220;Declaration of Competence&#8221; prior to the publication of the notice of
        extraordinary general meeting of shareholders, declaring that he fulfills all the qualifications of an external director under the Companies Law and that he has the requisite accounting and financial expertise. Such declaration also includes a
        confirmation of fulfillment of the qualifications of an independent director and member of an audit committee under the applicable SEC rules and regulations and the NYSE American Company Guide. Such declaration is available for review at our
        offices, at the address set forth above, during regular business hours.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 4 -</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following information is supplied with respect to Dr. Anghel, who is nominated for reelection as an external director and recommended by our Board of Directors to be
        reelected and is based upon information furnished to the Company by Dr. Anghel:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Dr. Michael J. Anghel</font>, age 82, has served as an external director of Ellomay since January 24, 2019. From 1977 to 1999, Dr. Anghel led
        the Discount Investment Corporation Ltd. (one of the major Israeli industrial holding groups) activities in the fields of technology and communications. Dr. Anghel was instrumental in founding Tevel, one of the first Israeli cable television
        operators and later in personally managing the founding of Cellcom Israel Ltd. (NYSE; TASE: CEL), the largest cellular operator in Israel. In 1999 he founded CAP Ventures - a technology venture company. From 2004 to 2005, Dr. Anghel served as CEO
        of DCM, the investment banking arm of the Israel Discount Bank. He led and took part in founding various technology enterprises and has served on the board of directors of various major Israeli corporations and financial institutions including:
        Elron Electronic Industries Ltd., Elbit Systems Ltd., Nice Ltd., Gilat Satellite Networks Ltd., American Israeli Paper Mills Ltd., Maalot (the Israeli affiliate of Standard and Poor&#8217;s), Hapoalim Capital Markets Ltd., Syneron Medical Ltd., Dan
        Hotels Ltd., the Strauss Group Ltd. and Partner Communications Company Ltd. He also served as the Chairman of the Israeli Center for Educational Technology (Matach). Dr. Anghel currently serves on the board of directors of InMode Ltd. (NASDAQ:
        INMD), BiolineRx Ltd. (NASDAQ; TASE: BLRX) and as Chairman of VascoDe. Dr. Anghel was a full-time member of the Recanati Graduate School of Business Administration of the Tel Aviv University, where he taught finance and corporate strategy. He
        currently serves as Chairman of the Tel Aviv University&#8217;s Lahav Executive Program. Dr. Anghel holds a B.A. in economics from the Hebrew University in Jerusalem and an M.B.A. and Ph.D. in finance, both from Columbia University in New York.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Required Vote</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="text-indent: 36pt; line-height: 1.25;">Pursuant to the Companies Law, the election of an external director nominated by a company&#8217;s board of directors
            (as is the case with Dr. Anghel&#8217;s nomination) requires the affirmative vote of a majority of the shares present, in person or by proxy, and voting on the matter, provided that either (i) at least a majority of the shares of non-controlling
            shareholders and shareholders who do not have a personal interest in the resolution (excluding a personal interest that is not related to a relationship with the controlling shareholders) are voted in favor of the election of the external
            director or (ii) the total number of shares of non-controlling shareholders and of shareholders who do not have a personal interest in the resolution (excluding a personal interest that is not related to a relationship with the controlling
            shareholders) voted against the election of the external director does not exceed 2% of the outstanding voting power in the company.</div>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">A &#8220;controlling shareholder&#8221; for purposes of the requisite majority is defined as a shareholder that has the ability to direct the activity of the company, other than an ability
        resulting only from serving as a director or having another position in the company. A person is deemed to control a company if he holds, alone or together with others, one half or more of the &#8220;means of control&#8221; in the company. Based, among other
        things, on their holdings in our shares and the 2008 Shareholders Agreement, Mr. Shlomo Nehama, our Chairman of the Board, Nechama Investments, Kanir and the estate of Mr. Hemi Raphael, are each deemed to be our &#8220;controlling shareholders&#8221; for
        purposes of the required &#8220;special majority&#8221;.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Companies Law requires that each shareholder voting on the proposal indicate whether or not the shareholder has a personal interest in the proposal (excluding, as mentioned
        above, a personal interest that is not related to a relationship with the controlling shareholders). Otherwise, the shareholder is not eligible to vote on this proposal. Under the Companies Law, a &#8220;personal interest&#8221; of a shareholder (i) includes a
        personal interest of any member of the shareholder&#8217;s family or of the shareholder&#8217;s spouse&#8217;s family (or a spouse thereof) or a personal interest of a company with respect to which the shareholder (or any of the aforementioned family members) serves
        as a director or chief executive officer, owns at least 5% of the shares or has the right to appoint a director or chief executive officer, and (ii) excludes an interest arising solely from the ownership of our ordinary shares. Under the Companies
        Law, in the case of a person voting by proxy for another person, &#8220;personal interest&#8221; includes a personal interest of either the proxy holder or the shareholder granting the proxy, whether or not the proxy holder has discretion how to vote.
        Shareholders who hold their shares through banks, brokers or other nominees that are members of the TASE should indicate whether or not they have a personal interest as explained above on the form of the deed of vote that we will file on MAGNA, the
        website of the ISA.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 5 -</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Proposal</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">At the Meeting, our Board of Directors will propose that the following resolution be adopted:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;RESOLVED, to reelect Dr. Michael J. Anghel as an external director for a second term of three years, commencing on January 24, 2022.&#8221;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Upon the receipt of a properly signed and dated proxy, which includes an indication as to whether or not the shareholder is a &#8220;controlling shareholder&#8221; or has a &#8220;personal
        interest&#8221; as explained above, and unless otherwise instructed in the proxy, either of the persons named in the enclosed proxy will vote the shares represented thereby <font style="font-weight: bold;">&#8220;FOR&#8221;</font> the above-mentioned proposal.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>ITEM 2</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">TERMS OF SERVICE OF DR. ANGHEL AS AN EXTERNAL DIRECTOR</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Background</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">At the Meeting, our shareholders will be asked to approve the terms of service of Dr. Anghel during his second term as external director. The compensation of an external director
        is governed by the Companies Regulations (Rules for Compensation and Expenses of External Directors), 5760-2000, or the Compensation Regulations, is required to be approved at the general meeting at which the external director is elected and cannot
        generally be revised during the external director&#8217;s term in office.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">General</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The proposed terms of service for Dr. Anghel during his second three-year term are as follows:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Compensation Regulations set forth a range of fees that may be paid by Israeli public companies to their external directors, depending upon each company&#8217;s equity based on the
        most recent financial statements. If reelected, Dr. Anghel will be entitled to receive annual and attendance fees equal to the minimum cash amounts permitted to be paid to our external directors pursuant to the Compensation Regulations based on our
        current shareholders&#8217; equity. The current minimum cash amounts permitted to be paid to our external directors pursuant to the Compensation Regulations are an annual fee of NIS 52,525 (equivalent to approximately &#8364;14,953 as of December 8, 2021) and
        an attendance fee of NIS 1,855 (equivalent to approximately &#8364;528 as of December 8, 2021) per meeting (board or committee). According to the Compensation Regulations, an external director is entitled to 60% of the meeting fee if he participated in
        the meeting by means of communication and not in person, and to 50% of the meeting fee if resolutions were approved in writing, without convening a meeting.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">All cash amounts set forth above are updated once a year based on increases in the Israeli consumer price index as compared to the base index set forth in the Compensation
        Regulations, and are subject to changes in the amounts payable pursuant to Israeli law from time to time.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">In addition, Dr. Anghel previously received from us, and will be entitled to continue to hold, an indemnification undertaking (which includes an undertaking to provide liability insurance) and an
          exemption letter, in the form approved by our Compensation Committee, Board of Directors and shareholders, most recently at the annual general meeting of our shareholders held on June 21, 2018, or the 2018 AGM, and based on the terms of the
          compensation policy applicable to our office holders, or the Compensation Policy, and is included, and will continue to be included, in our directors and officers&#8217; liability insurance policy.<font style="font-weight: bold;">&#160;</font>The form of
          indemnification undertaking and exemption letter was attached as Appendix B to the proxy statement published in connection with the 2018 AGM and furnished to the SEC on Form 6-K on May 17, 2018. The terms of our directors and officers liability
          insurance policy were most recently approved at the annual general meeting of our shareholders held on May 13, 2020 and included in the proxy statement published in connection with such meeting and furnished to the SEC on Form 6-K on April 8,
          2020.</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In accordance with our Compensation Policy, our Compensation Committee and Board of Directors approved, and recommend that our shareholders approve, the terms of service of Dr.
        Anghel during his second term as external director as set forth hereinabove, and determined that this resolution is for the benefit of the Company.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">For more information concerning the proposal for grant of options to Dr. Anghel, please see Item 3 below.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 6 -</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Required Vote</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Pursuant to Section 273 of the Companies Law, the terms of service of members of our Board of Directors that are in accordance with our Compensation Policy generally require the approval of our
          Compensation Committee, Board of Directors and the affirmative vote of the holders of a majority of the shares present, in person or by proxy, and voting on the matter. The Compensation Regulations require, among other things, that the payment of
          minimum permitted annual fee and attendance fee to an external director be approved at the shareholders&#8217; meeting in which such external director is appointed.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Proposal</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">At the Meeting, our Board of Directors will propose that the following resolution be adopted:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;RESOLVED, to approve the terms of service of Dr. Anghel as external director, as set forth in Item 2 of the Proxy Statement, and to determine that this resolution is for the
        benefit of the Company.&#8221;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Upon the receipt of a properly signed and dated proxy, and unless otherwise instructed in the proxy, either of the persons named in the enclosed proxy will vote the shares
        represented thereby <font style="font-weight: bold;">&#8220;FOR&#8221;</font> the above-mentioned proposal.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>ITEM 3</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">GRANT OF OPTIONS TO DR. ANGHEL AS AN EXTERNAL DIRECTOR</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">General</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">In addition to the terms of service for Dr. Anghel that are proposed under Item 2 above, at the Meeting our shareholders will be asked to approve a grant of options to Dr. Anghel during his second
          term as an external director.</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">As previously approved by our shareholders, each of our current and future non-employee directors are entitled to receive a grant of options to purchase 1,000 ordinary shares (currently
          representing less than 0.01% of our outstanding ordinary shares) annually (on August 1 of each year during his term as a director), under the terms and conditions set forth in our 1998 Option Plan for Non-Employee Directors, or the 1998 Option
          Plan. These options are valid for a period of 10 years (subject to certain exceptions detailed in the 1998 Option Plan) and have an exercise price equal the market value of our ordinary shares on the date of grant.</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Based on the terms of our Compensation Policy and the terms of our 1998 Option Plan, the options granted to our non-employee directors under the 1998 Option Plan vest in one
        installment on the first anniversary of the grant date of the options, provided that the option holder still serves as a member of our Board of Directors on such date (otherwise, the unvested options will immediately expire on the date of
        Termination of Service, as such term is defined in the 1998 Option Plan).</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Therefore, on each August 1 during his second term as external director, Dr. Anghel will be entitled to an option grant as described above.</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In accordance with our Compensation Policy, our Compensation Committee and Board of Directors approved, and recommend that our shareholders approve, the grant of options to Dr.
        Anghel as set forth hereinabove, and determined that this resolution is for the benefit of the Company.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Required Vote</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to Section 273 of the Companies Law, the terms of service of members of our Board of Directors that are in accordance with our Compensation Policy generally require the
        approval of our Compensation Committee, Board of Directors and the affirmative vote of the holders of a majority of the shares present, in person or by proxy, and voting on the matter. The Compensation Regulations require, among other things, that
        the grant of options to external directors be approved at the shareholders&#8217; meeting in which such external director is appointed. The grant of options to an external director generally requires the same &#8220;special majority&#8221; that is required for the
        election of the external director (or reelection in the event the external director is nominated by the board of directors), including the requirement to mark whether or not the voting shareholder has a &#8220;personal interest&#8221; in the adoption of the
        resolution. For more information concerning such &#8220;special majority&#8221; requirement, see &#8220;Item 1 &#8211; Reelection of External Director; Required Vote.&#8221;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 7 -</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Proposal</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">At the Meeting, our Board of Directors will propose that the following resolution be adopted:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;RESOLVED, to approve the grant of options to Dr. Anghel during his second term as external director as set forth in the Proxy Statement, and to determine that this resolution is
        for the benefit of the Company.&#8221;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Upon the receipt of a properly signed and dated proxy, which, with respect to the applicable portion of this resolution, includes an indication as to whether or not the
        shareholder is a &#8220;controlling shareholder&#8221; or has a &#8220;personal interest&#8221; as explained above, and unless otherwise instructed in the proxy, either of the persons named in the enclosed proxy will vote the shares represented thereby <font style="font-weight: bold;">&#8220;FOR&#8221;</font> the above-mentioned proposal.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSALS OF SHAREHOLDERS</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Any of our shareholders who intend to present a proposal at a shareholders&#8217; meeting must satisfy the requirements of the Companies Law. Under the Companies Law, only shareholders
        who severally or jointly hold at least one percent (1%) of our outstanding voting rights are entitled to request that our Board of Directors include a proposal, in a future shareholders&#8217; meeting, provided that such proposal is appropriate to be
        discussed in such meeting. Any shareholders of the Company who intend to present proposals at the Meeting must submit their proposals in writing to us at the address set forth above, attention: CEO, by no later than December 16, 2021. If our Board
        of Directors determines that a shareholder proposal is appropriate for inclusion in the agenda in the Meeting, we will publish a revised agenda for the Meeting no later than December 23, 2021 by way of issuing a press release and submitting a
        Current Report on Form 6-K to the SEC and the ISA.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">OTHER BUSINESS</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Board of Directors is not aware of any other matters that may be presented at the Meeting other than those mentioned in the attached Company&#8217;s Notice of Extraordinary General
        Meeting of Shareholders. If any other business is properly brought before the Meeting, it is intended that the persons named as proxies, or either one of them, will vote the shares in accordance with the recommendation of our Board of Directors.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zdbd7b39df8214f6a9395a6dbe070b972" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25;">By Order of the Board of Directors,</div>
              <div style="line-height: 1.25;"> <br>
              </div>
              <div style="line-height: 1.25; font-style: italic;"><u>/s/ Shlomo Nehama</u></div>
              <div style="line-height: 1.25;">Shlomo Nehama</div>
              <div style="line-height: 1.25;">Chairman of the Board of Directors</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 5.75pt; line-height: 1.25;">Tel Aviv, Israel</div>
      <div style="text-indent: 5.75pt; line-height: 1.25;">December 9, 2021</div>
      <div><br>
      </div>
    </div>
  </div>
  <div style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 8 -</font>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>exhibit_99-3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using EDGARfilings PROfile 7.7.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 99.3</font></u><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">2022 Extraordinary General Meeting</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">of Shareholders to be held January 20, 2022</div>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;"><img src="image00003.jpg"> FOLD HERE
          &#8226; DO NOT SEPARATE &#8226; INSERT IN ENVELOPE PROVIDED </font><img src="image00003.jpg"></div>
    </div>
    <div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS</div>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">PROXY</div>
    </div>
    <div> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">ELLOMAY CAPITAL LTD.</div>
    <div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">18 ROTHSCHILD BOULEVARD, 1ST FLOOR TEL-AVIV 6688121, ISRAEL</div>
    </div>
    <div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">JANUARY 20, 2022, 3:00 P.M., ISRAEL TIME</div>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 27pt;">The undersigned, a shareholder of Ellomay Capital Ltd., an Israeli company (the &#8220;Company&#8221;), revoking any
        previous proxies, does hereby appoint Kalia Rubenbach and Adv. Odeya Brick-Zarsky (each of them, or any substitute, hereinafter, the &#8220;Proxy&#8221;), or either one of them, with the full power of substitution, and hereby authorizes the Proxy to represent
        and to vote, as designated on the reverse side, all ordinary shares, NIS 10.00 nominal value per share, of the Company which the undersigned is entitled to vote at the Extraordinary General Meeting of Shareholders of the Company to be held at the
        offices of the Company at 18 Rothschild Boulevard, 1st Floor, Tel-Aviv 6688121, Israel, and/or via teleconference, on Thursday, January 20, 2022, at 3:00 p.m., Israel time (the &#8220;Meeting&#8221;), and any adjournment(s) or postponement(s) thereof, and
        hereby revoking any prior proxies to vote said shares, upon the following items of business and related resolutions as more fully described in the notice of and proxy statement for such Extraordinary General Meeting (receipt of which is hereby
        acknowledged):</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEN PROPERLY MARKED AND EXECUTED, THIS PROXY WILL BE VOTED IN THE MANNER DIRECTED HEREIN. IF NO DIRECTION
        IS MADE, THIS PROXY WILL BE VOTED &#8220;FOR&#8221; THE PROPOSALS SET FORTH HEREIN. PLEASE NOTE THAT YOU ARE REQUIRED TO INDICATE WHETHER OR NOT YOU ARE A CONTROLLING SHAREHOLDER OR HAVE A PERSONAL INTEREST, AS THE CASE MAY BE, IN CONNECTION WITH THE APPROVAL
        OF PROPOSALS 1a AND 3a BY MARKING ITEMS 1b AND 3b AS APPLICABLE, WHETHER YOU VOTE FOR OR AGAINST SUCH PROPOSALS. IF YOU FAIL TO MARK ITEMS 1b AND 3b, YOUR VOTE WILL NOT BE COUNTED WITH RESPECT TO THE SPECIAL MAJORITY REQUIRED FOR THE RELEVANT
        PROPOSAL, WHETHER OR NOT A VOTE WITH RESPECT TO SUCH PROPOSAL IS MARKED. IF YOU PROPERLY MARK ITEMS 1b OR 3b, AND NO DIRECTION IS MADE UNDER THE RELEVANT PROPOSALS, THIS PROXY WILL BE VOTED &#8220;FOR&#8221; THE RELEVANT UNDIRECTED PROPOSALS. FOR THE FULL TEXT
        OF EACH RESOLUTION AND ADDITIONAL DETAILS SEE THE RELEVANT ITEM IN THE PROXY STATEMENT.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">(Continued, and to be marked, dated and signed, on the other side)</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25;">&#160;<font style="font-weight: bold;">YOUR VOTE IS IMPORTANT. PLEASE VOTE TODAY.</font></div>
      </div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="zba6724b869e542f7b237a36f36f038c4">

            <tr>
              <td style="width: 50.00%;">
                <div>
                  <div style="text-align: center; line-height: 1.25;">&#160;<font style="font-weight: bold;">ELLOMAY CAPITAL LTD.</font></div>
                </div>
              </td>
              <td style="width: 50.00%;">
                <div>
                  <div style="text-align: center; line-height: 1.25;">&#160;<font style="font-weight: bold;">2022 Extraordinary General</font></div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 50.00%;" rowspan="1">&#160;</td>
              <td style="width: 50.00%;" rowspan="1">
                <div style="text-align: center; line-height: 1.25;">&#160;<font style="font-weight: bold;">Meeting of Shareholders</font></div>
              </td>
            </tr>
            <tr>
              <td style="width: 50.00%;" rowspan="1">&#160;</td>
              <td style="width: 50.00%;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50.00%;" rowspan="1">&#160;</td>
              <td style="width: 50.00%;" rowspan="1">
                <div style="text-align: center; line-height: 1.25;">&#160;<font style="font-weight: bold;">January 20, 2022,</font></div>
              </td>
            </tr>
            <tr>
              <td style="width: 50.00%;" rowspan="1">&#160;</td>
              <td style="width: 50.00%;" rowspan="1">
                <div style="text-align: center; line-height: 1.25;">&#160;<font style="font-weight: bold;">3:00 p.m., Israel time</font></div>
              </td>
            </tr>
            <tr>
              <td style="width: 50.00%;" rowspan="1">&#160;</td>
              <td style="width: 50.00%;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50.00%;">
                <div>&#160;</div>
              </td>
              <td style="width: 50.00%;">
                <div>
                  <div style="text-align: center; line-height: 1.25;">&#160;<font style="font-weight: bold;">This Proxy is Solicited On Behalf</font></div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 50.00%;" rowspan="1">&#160;</td>
              <td style="width: 50.00%;" rowspan="1">
                <div style="text-align: center; line-height: 1.25;">&#160;<font style="font-weight: bold;">Of The Board Of Directors</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div style="line-height: 1.25">
          <div style="line-height: 1.25">&#160;
            <table cellspacing="0" cellpadding="3" border="0" align="center" style="width: 80%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" id="z8e404ab9c48d4cf6a05471b89e56d71b">

                <tr>
                  <td style="width: 100%; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                    <div>
                      <div style="text-align: center; line-height: 1.25;">&#160;<font style="font-weight: bold;">Please Be Sure To Mark, Sign, Date and Return Your Proxy Card</font></div>
                      <div style="text-align: center; line-height: 1.25;">
                        <div style="line-height: 1.25;">&#160;<font style="font-weight: bold;">in the Envelope Provided</font></div>
                        <font style="font-weight: bold;"> </font></div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <br>
      <div>
        <div style="text-align: center; line-height: 1.25;"><img src="image00003.jpg"> <font style="font-weight: bold;">FOLD HERE &#8226; DO NOT SEPARATE &#8226; INSERT IN ENVELOPE PROVIDED </font><img src="image00003.jpg"></div>
      </div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="zd926e215dc134cfe8ac26dff00080175">

            <tr>
              <td style="width: 90%;">
                <div>
                  <div style="text-align: left; line-height: 1.25;">&#160;<font style="font-weight: bold;">PROXY</font></div>
                  <div style="line-height: 1.25">&#160;</div>
                </div>
              </td>
              <td style="width: 8%;">
                <div>
                  <div style="text-align: center; line-height: 1.25;">&#160;Please mark</div>
                  <div style="text-align: center; line-height: 1.25;">your votes</div>
                  <div style="text-align: center; line-height: 1.25;">like this</div>
                </div>
              </td>
              <td style="width: 2%; text-align: center; vertical-align: middle;" colspan="1">&#9746;</td>
            </tr>

        </table>
      </div>
      <div><br>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z45b8b86b9627416f8bdcdfbc5554ce27">

              <tr>
                <td style="width: 3%; text-align: left; vertical-align: top;">
                  <div style="font-weight: bold;">1a.</div>
                </td>
                <td style="width: 23%; text-align: left; vertical-align: top;" rowspan="2" colspan="1">
                  <div>
                    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">To reelect Dr. Michael J.
                        Anghel as an external director for a second term of three years, commencing on January 24, 2022.</div>
                  </div>
                </td>
                <td style="width: 8.24%; text-align: center; vertical-align: bottom;">
                  <div style="font-weight: bold;">FOR</div>
                </td>
                <td style="width: 8.24%; text-align: center; vertical-align: bottom;">
                  <div style="font-weight: bold;">AGAINST</div>
                </td>
                <td style="width: 8.24%; text-align: center; vertical-align: bottom;">
                  <div style="font-weight: bold;">ABSTAIN</div>
                </td>
                <td style="width: 1.04%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 3%; text-align: left; vertical-align: top;">
                  <div style="font-weight: bold;">3a.</div>
                </td>
                <td style="width: 22.24%; text-align: left; vertical-align: top;" rowspan="4" colspan="1">
                  <div>
                    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">To approve the grant of
                        options to the external director nominee as set forth in Item 3 of the proxy statement, and to determine that this resolution is for the benefit of the Company.</div>
                  </div>
                </td>
                <td style="width: 8.24%; text-align: center; vertical-align: bottom;">
                  <div style="font-weight: bold;">FOR</div>
                </td>
                <td style="width: 8.24%; text-align: center; vertical-align: bottom;">
                  <div style="font-weight: bold;">AGAINST</div>
                </td>
                <td style="width: 7.72%; text-align: center; vertical-align: bottom;">
                  <div style="font-weight: bold;">ABSTAIN</div>
                </td>
              </tr>
              <tr>
                <td style="width: 3%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%; text-align: center; vertical-align: middle;" rowspan="1">&#9744;</td>
                <td style="width: 8.24%; text-align: center; vertical-align: middle;" rowspan="1">&#9744;</td>
                <td style="width: 8.24%; text-align: center; vertical-align: middle;" rowspan="1">&#9744;</td>
                <td style="width: 1.04%;" rowspan="1">&#160;</td>
                <td style="width: 3%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%; text-align: center; vertical-align: middle;" rowspan="1">&#9744;</td>
                <td style="width: 8.24%; text-align: center; vertical-align: middle;" rowspan="1">&#9744;</td>
                <td style="width: 7.72%; text-align: center; vertical-align: middle;" rowspan="1">&#9744;</td>
              </tr>
              <tr>
                <td style="width: 3%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 23%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 1.04%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 3%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 7.72%;">
                  <div>&#160;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 3%; text-align: left; vertical-align: top; font-weight: bold;">
                  <div>1b.</div>
                </td>
                <td style="width: 23%; text-align: left; vertical-align: top;" rowspan="5" colspan="1">
                  <div style="text-align: justify;"><font style="font-family: 'Times New Roman',Times,serif;">In connection with Proposal 1a, please indicate whether you are a controlling shareholder or have a personal interest
                      in the Proposal (excluding a personal interest that is not related to a relationship with a controlling shareholder) and, if you indicate YES, please provide details.</font></div>
                </td>
                <td style="width: 8.24%; text-align: center; vertical-align: bottom; font-weight: bold;">Yes<br>
                </td>
                <td style="width: 8.24%; text-align: center; vertical-align: bottom;">
                  <div style="font-weight: bold;">&#160;No</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 1.04%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 3%;">
                  <div><br>
                  </div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 7.72%;">
                  <div>&#160;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 3%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%; text-align: center; vertical-align: middle;">
                  <div>&#9744;</div>
                </td>
                <td style="width: 8.24%; text-align: center; vertical-align: middle;">
                  <div>&#9744;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 1.04%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 3%;">
                  <div>
                    <div><br>
                    </div>
                  </div>
                </td>
                <td style="width: 22.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 7.72%;">
                  <div>&#160;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 3%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%;" rowspan="1">&#160;</td>
                <td style="width: 1.04%;" rowspan="1">&#160;</td>
                <td style="width: 3%; text-align: left; vertical-align: top; font-weight: bold;" rowspan="1">3b.<br>
                </td>
                <td style="width: 22.24%; text-align: justify; vertical-align: top;" rowspan="5" colspan="1">In connection with Proposal 3a, please indicate whether you are a controlling shareholder or have a personal interest in the Proposal (excluding a
                  personal interest that is not related to a relationship with a controlling shareholder) and, if you indicate YES, please provide details.<br>
                </td>
                <td style="width: 8.24%; font-weight: bold; text-align: center; vertical-align: bottom;" rowspan="1">Yes</td>
                <td style="width: 8.24%; font-weight: bold; text-align: center; vertical-align: bottom;" rowspan="1">No</td>
                <td style="width: 7.72%;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 3%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%;" rowspan="1">&#160;</td>
                <td style="width: 1.04%;" rowspan="1">&#160;</td>
                <td style="width: 3%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%; text-align: center; vertical-align: middle;" rowspan="1">&#9744;</td>
                <td style="width: 8.24%; text-align: center; vertical-align: middle;" rowspan="1">&#9744;</td>
                <td style="width: 7.72%;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 3%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%;" rowspan="1">&#160;</td>
                <td style="width: 1.04%;" rowspan="1">&#160;</td>
                <td style="width: 3%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%;" rowspan="1">&#160;</td>
                <td style="width: 7.72%;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 3%;" rowspan="1">&#160;</td>
                <td style="width: 23%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%;" rowspan="1">&#160;</td>
                <td style="width: 1.04%;" rowspan="1">&#160;</td>
                <td style="width: 3%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%;" rowspan="1">&#160;</td>
                <td style="width: 8.24%;" rowspan="1">&#160;</td>
                <td style="width: 7.72%;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 3%; text-align: left; vertical-align: top;">
                  <div style="font-weight: bold;">2</div>
                </td>
                <td style="width: 23%; text-align: left; vertical-align: top;" rowspan="3" colspan="1">
                  <div style="text-align: justify;"><font style="font-family: 'Times New Roman',Times,serif;">To approve the terms of service of the external director nominee, as set forth in Item 2 of the proxy statement, and to
                      determine that this resolution is for the benefit of the Company.</font></div>
                </td>
                <td style="width: 8.24%; text-align: center; vertical-align: bottom;">
                  <div style="font-weight: bold;">
                    <div>FOR</div>
                  </div>
                </td>
                <td style="width: 8.24%; text-align: center; vertical-align: bottom;">
                  <div style="font-weight: bold;">AGAINST</div>
                </td>
                <td style="width: 8.24%; text-align: center; vertical-align: bottom;">
                  <div style="font-weight: bold;">ABSTAIN</div>
                </td>
                <td style="width: 1.04%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 3%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 7.72%;">
                  <div>&#160;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 3%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%; text-align: center; vertical-align: middle;">
                  <div>&#9744;</div>
                </td>
                <td style="width: 8.24%; text-align: center; vertical-align: middle;">
                  <div>&#9744;</div>
                </td>
                <td style="width: 8.24%; text-align: center; vertical-align: middle;">
                  <div>&#9744;</div>
                </td>
                <td style="width: 1.04%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 3%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 22.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 7.72%;">
                  <div>&#160;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 3%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 1.04%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 3%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 22.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 7.72%;">
                  <div>&#160;</div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 3%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 23%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 1.04%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 3%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 22.24%;">
                  <div>&#160;</div>
                </td>
                <td rowspan="1" colspan="3">
                  <div>
                    <div style="text-align: center; line-height: 1.25;">CONTROL NUMBER</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 3%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 23%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 1.04%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 3%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 22.24%;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%; border-top: 2px solid rgb(0, 0, 0);">
                  <div>&#160;</div>
                </td>
                <td style="width: 7.72%; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                  <div>&#160;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 3%; padding-bottom: 2px;">
                  <div>&#160;</div>
                </td>
                <td style="width: 23%; padding-bottom: 2px;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%; padding-bottom: 2px;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%; padding-bottom: 2px;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%; padding-bottom: 2px;">
                  <div>&#160;</div>
                </td>
                <td style="width: 1.04%; padding-bottom: 2px;">
                  <div>&#160;</div>
                </td>
                <td style="width: 3%; padding-bottom: 2px;">
                  <div>&#160;</div>
                </td>
                <td style="width: 22.24%; padding-bottom: 2px;">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>&#160;</div>
                </td>
                <td style="width: 8.24%; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>&#160;</div>
                </td>
                <td style="width: 7.72%; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                  <div>&#160;</div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div>
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;">Signature__________________________________Signature,
                if held jointly_____________________________________Date_______________,2022.</font></div>
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Note: Your signature should appear
                the same as your name appears hereon. In signing as attorney, administrator, executor, trustee or guardian, please indicate the capacity in which signing. If two or more persons are joint owners of a share, this instrument must be executed
                by the person who is registered first in the Company&#8217;s Register of Members. When a proxy is given by a corporation, it should be signed by an authorized officer using the corporation&#8217;s full name and the corporate seal, if any, affixed. When
                a proxy is given by a partnership, it should be signed by an authorized person using the partnership&#8217;s full name.</div>
          </div>
          <div><br>
          </div>
          <div>
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">
                <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0P!WH# 2(  A$! Q$!_\0
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M/\8KR%?&C?\ /3]:CE\8,W\?ZTE-"EB8GJOV^+/WA5J"^B/\0KQL>+&S]_\
M6M&R\4,SJ-_ZTN;4S^L(]GMY5<<&K%<QX;OS=1J<YKIZT.VF[QN%%%%!8444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %96K7PM(BQ
M..*U:XSQO*T=DQ4]J3V)F[*YBW?B]0[+YGZU4'BQ?^>GZUY1>W]Q]J<;CUJ-
M;RX_O&L>9GFSQ#N>E:CXE$@X>L@:YD_>KC'N9FZDU%]HD3J:+G/.LV=C/K.?
MXJRKC4"Y^]7/M=N>]*LQ8<FK3,)3;1L_;R%QNK(O)7D?.::TAI.O6I9'.T1!
MW]31E^N:=CFI !BI<04V1;VQUI\!?S!S2$<U-;@;Q3M8:D=QX1+?:DSZU[II
MO_'HGTKP[PD/]*3ZU[CIO_'HGTK6)ZV"^$N44451WA1110 4444 -D;:A-<K
MJVNK:L5+8KIKG_4-]*\<\93RI<-M)ZTF<^(J.$;HU+GQ4N_[_P"M0OXK4QD;
M_P!:\ON;R?=]XU6^V3G^(UGS,\]8AGH%SX@#N3O_ %JJVNY_CKBC/+C))JN;
MN0'DT^8Q=5G976K[D/S5C-?DN?FK'-TQ'6F"5L]:2D9.;9J7%XS+UK+DD=B>
M:<SDBFKUI/5$<S(PSCO2[G/>I& H0"E&(^=D6Y@>M;&EEC(O/>LMP,UL:2!Y
MB_6FEJ-2/:O!.?(7Z5W?:N'\&?ZE?I7<=JU1[N'^!!1113-PHHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(RANM+10!%]G
M3T%'D)Z"I:*!61%Y">@IK6R$?='Y5/10%D<KK.FK(K86O)/%&F;)&^6O?+B
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]:V-*'[Q?K60W6MK2/\ 6+]:$7!GM?@O_4K]*[GM7#^#/]2OTKN.U:(]_#_
M@HHHIFX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %0W7_'NWTJ:H;K_CW;Z4"9X%\0A_I;?6N"0XKO?B$?\
M2V^M<%&,UAU/!Q7QLDQQ29YI<\4F.:;.04CBGVY_>4PGBGVX_>4QQW.^\)?\
M?2?6O<-._P"/1/I7A_A+_CZ3ZU[AIW_'HGTK1'M8+X2W1113.\**** "BBB@
M HHHH **** "BBB@ KC/'/\ R#W^E=G7&>.?^0>_TI2V,ZOP,^=[\_Z:_P!:
M8IQ3[\?Z:_UJ->E91/GJFY)G-(>*!Q1UIF0PGFMG23^\6L8CFMC21F1:>QI
M]N\%G]ROTKN>U<-X+'[E?I7<]JM'T&'^!!1113-@HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUL:3_K%^M8XY-;&F?ZQ:'N:0WL>V^#/]2OTKN.U<-X*_U"_2NY[5HMCZ'#_
M@HHHIFP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !4-U_Q[M]*FJ&Z_P!0WTH$SP+XA#_2V^M<%&<5
MWOQ"/^E-]:X%!FL'N>#BOC9+C-&:44WO5(Y (J2W/[RF$\4ZW'[RDRHG?>$O
M^/I/K7N.G?\ 'HGTKP[PC_Q])]:]QT[_ (]$^E:1/:P7PENBBBJ.X**** "B
MBB@ HHHH **** "BBB@ KC/''_(/?Z5V=<9XY_Y![_2E+8SJ_ SYYOSF]?ZT
MP<"G7W%\_P!:;U%8H^=J_$'6CI0!B@\U1F)U-;&E<2+]:QQP:V-+YD6C=EPW
M/;/!9S OTKN>U<-X+'[A?I7<]JT1]#A_@04444S8**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H;K_CW;Z5-
M4-U_J&^E ,\ ^(?_ !]M]:X6+I7>?$(?Z4WUK@D-8=3P,5\3'GK3NU)CBDSS
M3;.00U/;_?%1$<4^W/[RC<<3O?"7_'TGUKW#3O\ CT3Z5XAX2_X^4^M>X:=_
MQZ)]*U2/;P7PENBBBF=P4444 %%%% !1110 4444 %%%% !7&^./^/!_I795
MQGCG_D'O]*4MC.K\#/GG4/\ C]?ZTQ*6_/\ IK_6F*<5E%'SU3<D;I312@YI
M#Q3,F-;K6UI'^L6L0GFMG23^\7ZT(T@CV[P9_J5^E=QVKAO!9_<K]*[GM6B/
M?P_P(****9N%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFL&>V>"Q^Y7Z5W/:N'\&?ZE?I7<=JT6Q[^'^!!1113-PHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ J&Z_U#?2IJANO^/=OI0#/ OB$?]*;ZUP*#-=Y\0_^/MOK
M7"Q=*P:U/ Q6DF/%)B@]:=VJCD$)XIUN/WE1GK4]O]\4FBHZ'=^$?^/I/K7N
M.G?\>B?2O#O"7_'TGUKW#3O^/1/I6D3VL%\)<HHHJCN"BBB@ HHHH **** "
MBBB@ HHHH *XSQS_ ,@]_I79UQOCC_CP?Z4I;&=7X&?.]]Q?/]:;U%/U#_C]
M?ZTQ*Q1\[4UD &*#S3FZ4T51FQ!P:V-+YD6L9NM;6D?ZQ:$7#N>U^"Q^X7Z5
MW/:N'\&?ZE?I7<=JT1]!A_@04444S<**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **3(IKL N<T .+ 4WS%]:R[F^$9/-9
M=SK 12=U*YFZB1TWGIZBCST]17G\OB8+)C?^M'_"3C'W_P!:+F3Q$3T#ST]1
M2^<GJ*\\_P"$H&?O_K4L?B4,?O\ ZT7#ZQ$[\2J>].# UQ]MK@<CYJV;2^$F
M.:+FD:J9L45$C@CK4F13-1:*** "BBB@ HHHH **** "BBB@ HHHH **** "
MH;K_ %#?2IJANO\ CW;Z4"9X%\0A_I3?6N!2N^^(1_TMOK7!1C-8=3P<5\;)
M<<4W/-+FC'>FSD CBGVY_>5&3Q4EN/W@IHJ)WWA+_CY3ZU[AIW_'HGTKP[PE
M_P ?2?6O<=._X]$^E:(]G!?"6Z***9WA1110 4444 %%%% !1110 4444 %<
M9XY_Y![_ $KLZXSQQ_R#W^E*6QG5^!GSO?G_ $U_K3%-2:@/]-?ZU&O2LHGS
MU3<<#F@\4=*.M,R(SUK9TH_O%^M8[#!K9TD9D6GL:P/;?!9_<K]*[GM7#>"Q
M^Y7Z5W/:K6Q[^'^!!1113-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG+ZBG!P>E<%#XC#$?-^M='I5_P#:<<TRH5E+8W**!THH-@HHHH **** "D)
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M@,T7*59,WZ*BB<,@.:ER*9L%%%% !1110 4444 %%%% !1110 4444 %%%%
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M:'73Q5W8]KMYQ*,U8KE]&U6-T7+5T<4RR#(-6CT(24D2T444%A1110 4444
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MC.*P>YX&*^)CL<TX"C%&:JYR"$U+;CYQ41%2VY_>4BHG>>$O^/I/K7N&G?\
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M$RR+Q7I_A/1O,525KE/#FDFZ*G;FO9?#6G"VB7*XXJTM#OPM)MW9KZ99BWC
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M5]2,LSC/>NH\2:QYF]=U>=S,9)R?>LY,\O$5+L:<L^:V-)LC.X&*;I>FFZ<
M+FO0M"\-F,JQ2A(YZ=-S9'I?AH2[?DKK]/\ #8AP=GZ5LZ5IPB"Y6NA6)0.E
M6D>I2P\;:F59V B XJ[Y ]*MA0*,4TCJ44D5/LX]*<8!MQBK.*7%,.5'/7VE
MB8'Y:Y74O"P?<VS]*])*@U!/ K(>*5C*=&,CPC5] \A6.WI7#7:F.<KBOH#7
M=*$L3X6O)M;T)HIF?;421YU>A8Y0=*7.:64>6^VF@5-SSFK"XQ2'FEZT#BF(
M=&_EL#7HG@W4=K+S7F[<UT&@7OV9UYQ0M&=.'G9GT/IEUYR+S6OVKAO"=_\
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M2?6O<-._X]$^E>(>$O\ CY3ZU[AIW_'HGTK5(]O!?"6Z***9W!1110 4444
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MTC[24++7L6F:<MJBX&*N.QUX7#V?,RY!9I"HP*M 8I:*L]-*P4444#"BBB@
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MY/H*ZFM$?04_A04444S0**** "BBB@ HHHH *0C(Q2T4 9.JV:O;.2.U?/\
MXTMRE\V!WKZ-OAFV<>U>&^,[/==.V.]1)7.'&)*)YX@P*7/-/F7RWQ30.*G8
M\1Z,7M3#3LTN*!;$+$K78>";DI>KD]ZY-EXK:\/3>1< YQS2OJ;T)VD?1VF7
M2O;H >U:@Y%<%X;U+S0B[J[N,Y0&M4SWJ4^97'T444S4**** "BBB@ HHHH
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M2N*\'Q;(E^E=KVK5'OX?X$%%%%!N%%%% !1110 4444 %%%% !1110 4444
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M-Q]G<'.*]5\$ZD9Y%&:<3T\)4UL>MK]T4M,B.8Q3ZL]<**** "BBB@ HHHH
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M49,3H:V-+YD6L9NM;.D?ZQ:$7 ]L\%C$"_2NY[5P_@S_ %*_2NX[5HCZ##_
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MHKH<"C HL'LHG._V!'G[HI?[!C_NBNAP*,"@/91.=_L"/^Z*7^P(_P"Z*Z'
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M1UY+IH_TI?K7K7ACHE$3OPNYZA9?ZA?I5FJUE_J%^E6:U/:6P4444#"BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!4-U_P >[?2IJANO]0WTH$SP'XA#_2V^M<'&<"N^^(7_ !]-]:X!:P>YX.*U
MFQY/-.!XIE.%6<@$5+;GYZ8>E+;_ .MJ65'4[[PE_P ?2?6O<-._X]$^E>'^
M$?\ CZ2O<=._X]$^E:1/:P7PENBBBJ.X**** "BBB@ HHHH **** "BBB@ K
MC?''_'@_TKLJXSQS_P @]_I2EL9U?@9\\ZAS>O\ 6HU&!3[W_C^?_>IO:L4?
M.U?B \T#B@4&J,_(1N36QI/$BUCCK6QIG^L6C=EPW/;?!A_<K]*[CM7#>"O]
M0OTKN>U:+8^AP_P(****9L%-8X%.J*8X6@#EO%\O^@./:OGC5CF_D^M>]>+G
M/V)_I7@>I?\ '^_UK&IN>3C7<A7@4IYH_AI!UIGEBCBAN:4T@IW%YC!Q(/K7
MJ_@+E4KRAO\ 6"O5O 'W4J8K4[L)\1Z[:?<%7*IVGW!5RMCW([!1110,****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G/%G_ "#G^E?..MG_ (F,
MGUKZ.\6_\@V3Z5\WZU_R$I/K64]SS,<55'%*30/NTVA'D#E/-*QXI@H.:=BA
MH^\*[[PA+M*UP!^\*[7PLQ!6IZG10TD>VZ))N1:WZYCP\<QK73CI6J/<IN\0
MHHHIF@4444 <]XK_ .0:_P!*^;M<_P"0D_UKZ1\5_P#(.D^E?-NN_P#(2D^M
M9SW/-QQ6!RM&,4U.E/-)L\?J(33,\T4E"V&D:FGGYUKV#P-T2O'=.^^*]B\#
M=$JXH[L)\9Z6OW12TB_=%+5'MA1110 4444 %%%% !1110 4444 %!Z44'I0
M!F:@?W;5X;X\_P!>WUKW#4?]6U>'^._]<WUJ)'!BGH<+&:>>:A3K4XZ5-]#Q
M9:,,\4UA0>M*>E BSII_TE?K7K?ACHE>1:;_ ,?2_6O7?"_2.G%'?AMST^R_
MU"_2K-5K+_4+]*LUH>TM@HHHH&%%%% !1110 4444 %%%% !1110!@>)?^/)
MOI7A6OG,[_6O=?$W_'DWTKPG7?\ CX?ZU$CR\=N<NWWS2]11)]ZD6I1Y3%'%
M(QI6IE+J)#5/[U?K7M?PX/[M*\3'^M7ZU[5\-_\ 5)0OB/1P:]X]7'04M(/N
MBEK8]D**** "BBB@ HHHH **** "BBB@ HHHH **8\@6JDM_''U- FTBZQP*
MS[B]$6>:JSZU"JGYOUKE]4UQ/FPU)LSG421MW.O+%GYJR;CQ8BY&\?G7!ZKK
M;?-M:N0O-9F\PX8U#D<$L4[V/4;_ ,4*Z'#_ *UQNJZP90V&KDFU69N"QIHG
MDF/6IN<]6LY#[F[<N3DU5$SN>IJV+&27H*M6VB3%ONG\J2,8Q;1'9637!Z5;
MN-*,2YVUU6@Z&P8;E_2KVNZ<L,1^7M5\IK[*\+L\UECV5 3S6A?IM8UF]Z5C
MD:L2*:#S3*>*!-B'@5)IG_(0C^M1/TJ32_\ D(1_6DS2BO>/H[P9_P @U/H*
MZNN4\&?\@U/H*ZNM5L?14_A04444RPHHHH **** "BBB@ HHHH **** "L3Q
M%$#I\G':MNLS6DWV;CVH9,_A/F[Q';D:BYQWK'Z#%=MXFTUOM+MM[UQ,JE)2
M#66Q\_7C[P@%*3Q2]J8:#GW'*:;)R:*,<TFBD['?^!;S[/(N37M6FWPG1>:^
M=M#NO(=<'%>Q^$KTSJO-5!GJX2M?0[NBD'04M:'IA1110 5C:^^+!_I6NYPN
M:YKQ'=*+*09[4F14=HG@GBB8_;W&>]5_#:^9?K]:9XC8R:@^/6KWA* G4$)'
M>L7+4\51_>'N/AZTVVT9QVKJXQA *R]$A"V,?':M<<5LMCV:<;(****9H%%%
M% !1110 4444 ?(Q&!3.]+NS28K)'RS'8I,4 TI/%#)$/%1'DBGDU&3\U)[%
M16IZ9X .UTKV>R;*+7B'@63#I7M&FON1:N&Q[>$?NV-6BBBK.X**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MH;K_ (]V^E35#=?\>[?2@&> _$(_Z6WUKA(QD5W?Q"'^EM]:X.,XK#J>!BOB
M8XCFG@<4F*,]JJYR"$U+;CYQ41%2VY_>4AQ.\\)?\?2?6O<-._X]$^E>'^$O
M^/I/K7N.G?\ 'HGTK5(]O!?"6Z***9W!1110 4444 %%%% !1110 4444 %<
M;XX_X\'^E=E7&^./^0>_TI2V,ZOP,^>-0XO7^M,7FG:@?]-?ZU&IQ6,3YZIN
M2$8IHYI<YI.E49,0\&MG2>9%K$)YK9TDXD6A&D$>W>#/]2OTKN.U</X+/[E?
MI7<=JT1[^'^!!1113-PJ*;[E2U%-]R@3.)\6C_0W^E>"ZH,7S_6O>?%I_P!#
M?Z5X-J9S?/\ 6LI[GD8S<KK3CQ31P*":#S1R\TK# IBG%.)R*8R,<R#ZUZMX
M#X5*\IZ.*]5\!<JE2G[QUX7XCUVR^X*NU2LQ\@J[6Q[D=@HHHH*"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH YSQ9_R#G^E?..MC_B8R?6OH[Q9
M_P @Y_I7SAKA_P")C)]:RGN>9CBHII2.*8O2GYS0>0]P4<TK#BCI2%LTKZC0
MP#YA7:>&!\RUQ6?F%=KX7.66CJ;T/B/8_#O^K6NH'2N8\/?ZM:Z<=*U1[U+X
M0HHHIF@4444 <]XK_P"0:_TKYNUS_D)/]:^D?%7_ "#I/I7SAKH_XF4GUK*>
MYYN.*0&%HS2 \4"A'CCB*;CFG9S2'BC9 C1T_P"^*]@\#=$KQ[3SEQ]:]A\#
M=$IQ9WX/XCTM?NBEI%^Z*6M#VPHHHH **** "BBB@ HHHH **** "@]**#TH
M S-0_P!6U>&^//\ 7M]:]QU _NVKQ#QWS,WUJ)['!B]C@HQ4G>F(<4_K4(\5
M[C@.*8U.SBFL*8%K3?\ CY7ZUZSX8/"5Y+II_P!*7ZUZUX8'"41.S#7N>H67
M^H7Z5:JM9?ZA?I5FM3W([!1110,**** "BBB@ HHHH **** "BBB@#!\2_\
M'DWTKPK7QB>3ZU[IXE/^A-]*\*UXYN)/K4R/+QVYRS??-+T%(_#FC.:SN>4Q
M1S2,*7I1UIB(E'[U?K7M?PX_U:5XKTE7ZU[3\-S^[2E%^\>A@OB/5AT%+2#[
MHI:V/:"BBB@ HHHH **** "BBB@ HHI":  D"HWF51R15:ZN!&#S7'ZSXA%L
M2-WZT7,IU5'<Z6]OD13AA7%:QKOE%L/^M85WXKWY&_\ 6N5U+63.3\U9N1P5
ML1=:&CJ'BEU8@.:Q)_$+R=6-8MRYD;.:IMD5G=W.1UF]#4FU RGK5.1"_.*@
MART@%=+IVFF?:-O6K6I'*VSG%MG+=#6MIU@[N,J:[6S\*>8H.S]*WK'PIY;
M[/TH43;ZO)F-HV@B8KE*[2U\*($!V#\JT=+T@0%?EKIXHPJ 8JN4[Z-!):G/
MVF@I!R%%<SXOMQ'$W':O2R!BO/\ QO\ ZMJIEUH*,-#QC41\[5DL.:U=2.':
MLHG)J#PY[BJ*4\&D!Q2]:1F+C*U)IH_XF,?^]41.!4VF<ZA'_O5+-J6Y]%^#
M/^0:GT%=77*>#/\ D')]!75ULMCZ&G\*"BBBF6%%%% !1110 4444 %%%% !
M1110 57NX_,B(JQ2,,B@&>;>*-)'D.^VO%=43R[QA[U]&>*(?] <X[5\]ZXF
M+]_K6,EJ>1C8J+,T'BE--%.S3//0#K2L,4@.*&.:9'4GMK@QN.>]>O\ @"Y\
MP)DUXKG#"O4_ %QLV<TEHSMPKM,]L0Y44ZJ=I-YB#FKE:GN)W04444#(+MML
M+'VKS?Q/J.$==U>A:FVVT<^U>(^*[_%PZYJ9''BY\J.,O_W]\3UYKJO"=GBZ
M1L=ZY.W/GWP^M>I^%]/QL;%915V<%%-RN>G:4NVS0>U7ZK6*[;=1[59K<]J.
MP4444#"BBB@ HHHH **** /D(4[/%/:$@=*BY!K-H^6: =:<>:#TI%ZTMQ#2
M*81S5AQQ4..:36A2.X\&OL=:]HT:3<BUX=X8E$;KS7LGAR8.J\U4#U<(SK!T
MHI!TI:T/3"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ J&Z_U#?2IJANO^/=OI0#/ OB$?]*;ZUP*5WGQ#_X^
MV^M<+%TK#J>!BOB9)VIN.:#UIW:FT<@AZ4^W'[RHC4]O]\4;#B=YX2_X^4^M
M>X:=_P >B?2O#O"7_'TGUKW#3O\ CT3Z5JF>W@OA+E%%%,[@HHHH **** "B
MBB@ HHHH **** "N,\<_\@]_I79UQOCC_CP?Z4I;&=7X&?.U^/\ 37^M1CI4
MVH?\?K_6HUK*+/GJCU%%!YH-"TT8^8PCFMC2O]8M9+=:V-)_UBT,U@SVSP7_
M *E?I7<]JX?P9_J5^E=QVK1;'OX?X$%%%%,W"HY1E:DI",B@#B/%T1^Q.?:O
M =3&+]_K7T7XO0?V>_T-?.VK_P#(0D^M93>IY6-5BN.132*5*>PXI=3RR.G"
MD'6E;I3$QC<N*]6\ #Y4KRD??%>K^ B J5*TD=N$^(]<M/NBKE4K,Y45=K<]
MR.P4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YSQ;_ ,@Z
M3Z5\WZV/^)C)]:^D/%G_ "#G^E?..N?\A&3ZUE/<\S',HKTIPI$IYZ4'D,0\
MTS%.'6E:E;4"+^(5W?A*$N4KA1]X5Z7X(C#;*:>IU8?XCU/0HMD:UT0Z5E:9
M&%1:U:U/=AL%%%%!84444 <]XJ_Y!TGTKYQUW_D(R?6OH[Q7_P @U_I7S?KA
M_P")D_UK*:U/-QQ1 XI:</NT@'-,\>XHI&YIQZ4SO4O4$7].'SBO8_ W1*\?
ML/OK7K_@;HE5$]#"?$>F+]T4M(OW12UH>T%%%% !1110 4444 %%%% !1110
M 4AZ4M!Z4 96H_ZMJ\1\=?ZYOK7N&H?ZMJ\.\>?Z]OK436AP8M:'!J.:E%,C
MI3UJ;:'BO<#UI2>*4=*8U BUIO\ Q]+]:];\,=$KR73/^/E?K7K7AGHE$=SO
MPNYZA9?ZA?I5FJUE_J%^E6:U/:6P4444#"BBB@ HHHH **** "BBB@ HHHH
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M/4]0LO\ 4+]*LU6LO]0OTJS6A[:V"BBB@84444 %%%% !1110 4444 %%%%
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M&0,HJ:LK39O,1>:U:U/;B[H****!A1110 4444 %%%% !1110 4444 %%%%
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MJXWPE+OB7Z5V7:K6Q[U%W@%%%%,U"BBB@ HHHH **** "BBB@ HHHH ****
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *ANO\
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M\,6&YHVQ6<;-GGT[RE<]9\/)LL4'M6U6=I$>RU4>U:-;'MP^$****"@HHHH
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M1WX/XCTI?NBEI%^Z*6K/:"BBB@ HHHH **** "BBB@ HHHH *1ONFEI&^Z:
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M-D&@1L5Z98Q[(@*Y#P9;9LD..U=O&NT8K:.Q[N'A97'T444SI"BBB@ HHHH
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M'?>$A_I*5[?IW_'HGTKPGPE.#=H/>O==-.;1/I5Q=SV\%\)<HHHJCN"BBB@
MHHHH **** "BBB@ HHHH 0G KBO&[9L'^E=C,VU:X+QG< VCC/:IEL8UG:+/
M"+X8O7^M,'(I]\<W;_6F)Q62/GYZL0KBD S4C<TT<52V(8=*6%OWR_6FL:;$
M?WR_6@<-SW;X>G-NOTKTD=*\O^'LN(%^E>FHVX5HMCZ'#OW$/HHHIFX4444
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MC_CZ<>]?1'CBV\RR8 =J\$OK,Q73DCO64]SR<9&S*HXHZTA/:A30M3RQ",4
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M$U<\Q\8:*!$Q5:\@O["2*1OEKZ5U?3Q=QD$9KS'Q'X>$08A*F2/,Q-#6Z/*
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M"X1<M79B12.M:(]RG/FC<?13=XI=PIF@M%&:* "BBB@ HHHSB@ HI-PI-PH
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MB&+;9ZK_ &N,?>H_M<?WJ\\&N<?>H_MO_:IIG3]8/07U@ ?>K/N?$2Q9^?\
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M/F.E5SURUG\U,YJU7+:)J:R1+S7312!US5G9"5T24444%A52\G\E,YJW7/\
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M$N48J<9KW#3X0EL@QVJXH]3!PLM2V@PHIU%%4=X4444 %%%% !1110 4444
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M:8[NN5/6O5?#OAY'B4LHI=.\+B,J=GZ5V^EV0MXP,5:B=^'P[4KLBM=)2$#
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M0H,K70+I4*_PBK<5LL?05:1T4\.HC8;=5'2K 4#I0!BEIG2E8****!A1110
M4QQD4^B@#"U6S\Y",5S1T3YR=GZ5WSQ!^M0_8T]*FQC.ES,XC^Q?]FC^Q?\
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M,T70_)5<I7:V-HJ(.*GCLDCZ"K*H%%:'3"DHB")1VIP&*6B@U"BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH 8RY%4YK,2=JOT4":3,9M+4GI3AIBXZ5K8%+B@GV:,?^RUSG
M%68K,)VJ_@44#Y$-1=HQ3J**"@HHHH **** "BBB@!#R*J3VHD[5<HH$U<R&
MTQ2>E-_LI?[M;.!28%!/(C(72U5L[15Z*W"#I5G I:!J*0@&!2T44%!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "-]TUYAXZEVAZ].?[A
MKR/XB3;-_/K2;.;%? >5WTNZ;\:[7PC:>:%.*\^:3S+C\:]>\!VN^)#BLE\1
MYV'C>1Z+HD'E1 8[5MU4M(?+45;K8]B*L@HHHH*"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH/2@"
MI=7 C0\UXS\0[CS2^#7IVNW7DHW->->+;H3NW-9S9Q8J?NV.*MHB]P/K7N?P
M^A"P+D=J\@TRV\R4$#O7MW@F$QPKQVI01RX3XSN@,"EH[45J>N%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4AZ&EJ*5L*: .$\9W?DHW->,:O>>=*PSWKT_P ?W&$?FO&9Y=\_
MXUG)H\?%-N=CL/#-IYS*<5[/X;M_*B7CM7FG@6U\T)Q7L&G6_E(.*J.QU86%
MM32HHHJCN"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *R]3NQ AR:TF8*.:XCQ??^3$V#VI,SJR
MY8W.$\<7XG#@&O,DC+S_ (UT.LWYN'8$U1T^V\V4$"L7N>+4J<TCU7X=VX$:
M9%>K1J%48KSSP-;F*-.*]%'05M'8];#KW!:***9T!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4457N)
M?+7.: *U_<")"<UY=XRU#<C#=74^(-6$<;?-7D_B#5/M!8;JF3T.#$U=+'+7
M,VZ4\]ZZGPO9_:&7BN/(W2?C7IO@.UWE.*Q2=S@HKFD>D^'+3R$7CM75CI6=
M80>6B\5HUNMCVJ:M&P4444S0**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC2WBC>*S!=KZTINU]:06T-+S!1O%9?VM?6I$NE/>@1I YI:@CE4CK4GF+ZT
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MC'#BG#FHRU.5P*&&PX\4T\T,X--#4+<-QXXIV,U%NYIX< 4!L!.*;CFAFR:
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M 9)TF/\ NBD_L>/TK7HH R/[(C]!^5,;18C_  BMJB@#!.@PG^$?E1_8$/\
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M'I3J* &[!Z4;%]*=10 W8OI2>6OI3Z* &^6OI2>6OI3Z* &^6OI2>6OI3Z*
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !129%&10
MM%)D4M !1110 4444 %%%% !1110 4444 %%%&: "BBB@ HHHH **** "BBB
M@ HHHH **,T9H **,T9H **,T4 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4449H **,T9H **,T9H **,T9H **** "BBB@ HHHH **** "B
MBC- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !11FB@ HHHH **** "BBB@ HHS10 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !11FC- !11FC- !11FC-
M!11FB@ HHHH **** "BBB@ HHS1F@ HHS1F@ HHS1F@ HHHH **** "BBB@
MHHHH **,T9H **,T9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'Z5JK/JH7=WKH_$H)1ZX?1D/]LCZT >]:4^^S0^U7ZSM&_X\8_I6C0 4444
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MUT6\$]NI)[5L@Y%>5^'=>VA(]U>D:?<>?"&S0!=HHHH **** "BBB@ HHHH
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M+UH?[U>M^&9L6:#/:O+=5&W6,^]=YX<N\0HN:0'?QG*T^H+5MT0-3T %%%%
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MKAAD'FG<+@]O)>2Y&3S7I7@S3S#&NX5B>&-)^T;2R_G7I6GV"VRC H"^A?1
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MH **** "BBB@ HHHH **** ,K6O^/1OI7D>J_P#'TWUKUS6_^/1OI7D>I_\
M'VWUIC3-#PYG[4OUKUFR_P"/=?I7E7AP?Z2OUKU6S_X]U^E(18HHHH ****
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M[^E;-MX7Y'R?I77VNGJI^[6O#;*H'% ,R=$TL6@'RUT0&!2*@7H*=0(****
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M4Q]^D;Q.NW&^FA$VO(&B<UYW#\NKCZUT^I:VLT3#=7(Q3;M1#>] SV?P_/\
MZ(@SVKHT.5KAO#UU^Z09KMK<YC!H8,EHHHI""BBB@!K_ '#7GGBYL.U>AO\
M<->=^+AEVH Q-+.7%>BZ)_JQ]*\YTH8<?6O1M$_U8^E &Y1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% &5K?_'HWTKR/5.+MOK7KFM?\>C?
M2O(]5YNF^M-#1I>'&_TI?K7J]G_Q[K]*\G\.+_I2_6O6++_CW7Z4A%BBBB@
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MA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[XKT31/]6*\YTHY85Z-HG^K'TH W**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH RM;_ ./1OI7D>I_\?;?6O7-:_P"/1OI7DFJ_\?3?6J0[
M&GX<Q]I7ZUZK9_\ 'NOTKR?PXW^E+]:]8LO^/=?I4B+%%%% !1110 4444 %
M%%% !5:\_P!2:LU6O/\ 4F@#SKQ)]UZXK1\?VP/K7:^)?N/7#:.?^)R/K3:
M]VT?_CQ3Z5HUG:-_QXQ_2M&D 4444 %%%!Z4 4KS_5M7C?C+_C\_&O8KT_NV
MKQ_QAS=_C04F=%X)_P!2M>@,-UN1[5P/@L?N5KT&,9CQ02SSSQ'8Y9VQ7$P2
MF'4E'O7K.N68:!VQVKR+4/W.J?C3&D>FQW@_L7KVKSB\G,VI,OO6^FH'^S-N
M[M7,6O[[5?QHL%CN/#MC\Z/BO1(UVVZCVKGM!LP($;':NE88BQ[4A' ^-/\
MCW;Z5R/A/_C_ /\ @5=?XS'^CM]*Y+PI_P ?WXTTQGL5A_JE^E:(Z5G6'^J7
MZ5HCI0Q!1112 **** *.J?\ 'E)]*\-U_']KG_>KW+5?^/)_I7A.OM_Q./\
M@5 '8^&_N)7I-C_J17F_AG[B5Z18_P"I%-H"U1112 **** "BBB@ IDO^K-/
MIDO^K- 'FWBK'FM7)P?\?"_6NH\6']ZWUKEK7F=?K0"/5?#'_'LOTKI*YSPU
M_P >R_2NCH **** "BBB@ HHHH 0_=->8^/^C5Z<WW37EWQ!/#4 9W@@_O%^
MM>L6I^05Y'X&.95^M>N6OW!]* +=%%% !1110 4444 %%%% !1110!B:S_JS
M7D_BC[QKUC6?]6:\F\3_ 'C312-?P!]]:];3[@KR3P!_K%KUM/N"AB8ZBBBD
M(*KWAQ Q]JL51U.4+:OSVH \W\2W0#.,UQ%B"^K*?>M7Q+>DWC*#WJIHD!DO
M4;'>JV ]H\/1XL$^E;8XK+T-=MD@]JU*D HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 ,= ZX-<QXDT\/:,0.<5U54[^W\^(KB@#Y^O[26VNV8 ]
M:V/#VJ2).H<\9KJM=T  ,^RN&EB:RE) Q@TTP/6+35X_*7+=JM-JT>/O5Y%%
MK\B<;CQ4K^(I,?>-%@9V6NZP-K;6K@-0N9+F3CGFF7&JR7)QDFM+1[$W;*2,
MT6!&AX;TXR[2RUZ?I%J($&!6/H>E"%5^6NJABV"F!/1114@%-8X%.J&X;;&3
M0!@>))P+)QGM7C8?S-9(]Z](\373?9W ->9:<K2:WT_BIHI'JWA^VQ$AQ7:0
MC$8%8FA6V+.,X[5O*,"D2+1110 'I6%J\'F(W%;M5+N'?&U 'B/BA/*G/UKK
MO 4X\M<FN<\=0E)S@=ZM^"9VC513Z%=#V!&# 8I]4+&4N@J_2)"BBB@!DGW:
MY+Q1_P >;_2NMD^[7(^*@?L3X]*8TCRO3&_XG9_WJ]IT9O\ 14^E>(::&_MP
M\?Q5[9HN?LJ?2E<&;R]*6D7I2T""BBB@ HHHH **** "BBB@ JGJ'^I-7*IW
M_P#J30!YGXG^X]<MX9(_M;_@5=3XI4^4]<EX8#?VO_P*FBD>\Z=_QZ)]*N53
MTW_CS3Z5<I$A1110 4444 %%%% #6^[6!KG_ !Z/]*Z!NE<_KH/V23Z4#2N>
M-71_XGG_  *O6_#1_P!#3Z5X]=AO[=_X%7KWAG/V-,^E%[C9U<?W:?3(_NT^
M@D**** "D;[II:1ONF@#SWQC=&+=S7GH)NIL]>:Z_P ?NP9L5S&@0&=QD=Z$
M-'H_@^'RXEX[5VW:N;\/P>5&O%=)0)A1110 A&16'XABS8O]*W:S-83?:,/:
M@#PRX1HM68^]=[X=O<[%S7,:S9F.Y9P.]2>'+EQ>JOO0-L]FMCNA4^U355T\
MYM4/M5J@04444 -?[IKSOQ<<,U>BO]TUYWXO4DM0!Q\%R(VZUT-CJ@5?O5PM
MU,\3G%$.I2*.IH'8]'.L#^]2?VP/[U>>'59,]32C5),=30!Z"=9&/O4^#5PT
MH&ZO-VU63U-6;'4Y#..:;0CV6PO!(%YK=B.4!K@-"NV<+DUW=J<Q T@)Z***
M "BBB@ HHHH **** "BBB@ HHHH RM:_X]&^E>0ZRV+E_K7KVM_\>C?2O&M<
MW?:'^M-#3(],N_+N!SWKM(=7 B W=J\P69XI,U<359 ,9-&X,]%_M@9^]1_;
M _O5YZ=4D]32#59/4T@L>A'6!_>J:#5@Q'S5YJ^JR#N:T-.U)W8<T["/8M)N
M/- YK;'2N0\,3&1%S77#I2 6BBB@ JM>?ZDU9JM>_P"I- 'G?B4_NWK@]';_
M (G0_P!ZNW\39*/7#:,C?VR./XJ;&SWG1O\ CQC^E:59NB_\>,?TK2I""BBB
M@ H/2B@]* ,V_/[MJ\?\7$?:^?6O8;X9C:O&?&6X7G'K1<JVAUG@IOW*UZ)
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44 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00003.jpg
<TEXT>
begin 644 image00003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  +  L# 2(  A$! Q$!_\0
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<HD8 9([  5KA:3KQLM]S/%U5AW=[;?U_78__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
